Philadelphia College of Osteopathic Medicine

DigitalCommons@PCOM
PCOM Psychology Dissertations

Student Dissertations, Theses and Papers

2006

Study of the Cognitive Functioning of Medicated
and Non-Medicated Elementary School-Aged
Children Diagnosed with Attention Deficit
HyperactivIty Disorder
Janet Friedman
Philadelphia College of Osteopathic Medicine, jerseyjan@comcast.net

Follow this and additional works at: http://digitalcommons.pcom.edu/psychology_dissertations
Part of the School Psychology Commons
Recommended Citation
Friedman, Janet, "Study of the Cognitive Functioning of Medicated and Non-Medicated Elementary School-Aged Children Diagnosed
with Attention Deficit HyperactivIty Disorder" (2006). PCOM Psychology Dissertations. Paper 48.

This Dissertation is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been
accepted for inclusion in PCOM Psychology Dissertations by an authorized administrator of DigitalCommons@PCOM. For more information, please
contact library@pcom.edu.

Philadelphia College of Osteopathic Medicine
Department of Psychology

A STUDY OF THE COGNITIVE FUNCTIONING OF MEDICATED AND
NONMEDICATED ELEMENTARY SCHOOL-AGED CHILDREN
DIAGNOSED WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

By: Janet Friedman
Copyright 2006

Submitted in Partial Fulfillment
Of the Requirements for the Degree of
Doctor of Psychology
August 2006

PIDLADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
DEPARTMENT OF PSYCHOLOGY
Dissertation Approval
This is to certify that the thesis presented to us by _J_C4_·_tj_a.,_t__S_f!._-_'_'e.._J_M_D\_tl
___
on the

I .JI

I~

1

C't-,!I-____, 20LlG.., in partial fulfillment of the

day Of-----';V}
__

requirements for the degree of Doctor of Psychology, has been examined and is
acceptable in both scholarship and literary quality,

Committee Members' Signatures:
George McCloskey, Ph.D., Chairperson
Virginia Salzer, Ph.D.
George DuPaul, Ph.D.
Robert A. DiTomasso, Ph.D., ABPP, Chair, Department of Psychology

III

Acknow ledgements
I would like to thank my dissertation chair, Dr. George McCloskey for his
encouragement and support. His assistance and expertise made this study possible. I am
most appreciative for his patience, reassurance and good nature throughout this project. I
would also like to thank the members of my committee, Dr. Virginia Salzar and Dr.
George DuPaul for their time and commitment. Their contributions substantially
improved this study. Dr. Steve Krulik graciously served as an unofficial "fourth"
committee member.
Special acknowledgements are extended to my friends and colleagues from Berlin
Community School for their continued support and encouragement. A special thank-you
goes to my superintendent, Dr. Leonard Binowski. I am grateful to my friends and
colleagues who provided much needed data, especially Dr. Jeri Goldman, Lori Lennon
Carol Ritting, and Dr. Cynthia Shulmeyer. I am appreciative of my friends that patiently
stood by me while I completed my studies, particularly Elizabeth Greenberg, who
convinced me that I needed a social life during this process. Gladys Krulik and Denise
Winkler provided a sounding board and offered sage advice. A special thanks goes to my
friend, Dr. A vivah Dahbany for her support, knowledge, and never-ending patience.
I would especially like to thank my family who provided perspective, grounding,
and pride. My husband Michael's patience, love, and support have sustained me in all
my endeavors. My children, Marisa and Josh provided technical assistance, as well as
unconditional love. Finally, my pet Shelby patiently stood behind me while awaiting her
daily walks. I will always treasure those moments.

IV

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is a serious disability
that has been shown to adversely affect cognition, affect, and behavior. Research using
traditional measures of cognitive functioning, such as intelligence tests has shown that
children diagnosed with ADHD pelform poorly on cognitive measures of processing
speed, and on working memory in particular (Kerns, Mclnerney & Wilde, 2001; Weiler,
Bernstein, Bellinger & Waber, 2000). Mahone, et al. (2003), note that reviews involving
the Wechsler Scales for children suggest that Full Scale IQ scores (FSIQ) on the WISCIII average 5 to 6 points lower than scores in the WISC-R. It was hypothesized that
changes on revised subtests of the WISC-III Performance Scale may place ADHD
children at a disadvantage if their performance on these subtests is compared to their
pelformance on analogous WISC-R subtests. Mahone, et al. (2003) theorize that
increased executive demands resulted in lower FSIQ scores and call for further analysis
upon future Wechsler revisions.
Although results are equivocal, research suggests that psychostimulant medication
may ameliorate ADHD cognitive deficiencies that adversely impact working memory and
processing speed. Brown and Borden (1989) suggest that stimulant drug improvement
occurs primarily on rote or simple tasks, but measures emphasizing the processing of
higher-order information may be less influenced. Barkley (1998) indicates that the
impact of drugs upon behavior and concentration was most salient, with performance on
intelligence tests unaffected by medication. However, most of these studies extrapolated
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IQ scores either from short forms or from several subtests of the Wechsler scales.
Research using more traditional measures of cognitive functioning (e.g., standardized
intelligence tests), and focusing on long-term effects of cognitive performance (Gillberg,
et aI., 1997; Livingston, Mears, Marshall, Gray & Haak, 1996; Mahone, et aI., 2003),
suggests that results depend on the measures and methods used.
As part of the initial validation of the revised WISC-IV, an ADHD group was
compared to a matched control group. Additional research called for investigations
comparing the performance of medicated ADHD children with nonmedicated ADHD
children. This research used the Wechsler Intelligence Test for Children-fourth edition
(WISC-IV) to assess the cognitive performance of medicated ADHD children and
nonmedicated ADHD children. Results were used to answer the questions: "Are there
differences in IQ scores between ADHD children and normal controls, and between
medicated ADHD children and nonmedicated ADHD children?"
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Chapter 1
Introduction
Statement of the Problem

Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most frequently
diagnosed disorders in the pediatric population, with an estimated prevalence between
4% - 12% of all school-aged children (APA, 2000, DSM-IV-TR). ADHD is a serious
disability with long-term consequences. There is some evidence, albeit equivocal, of
cognitive impairments in ADHD in terms of response inhibition, working memory, and
lapses in attention as reflected by variability in response time. Previous studies have
shown that children diagnosed with ADHD pelform poorly on neuropsychological tests,
particularly on cognitive measures of processing speed and working memory (Kail, 2000;
Kail & Salthouse, 1994; Kalff, et al., 2002; Karatekin and Asarnow, 1998). Research
suggests that Wechsler Intelligence Scale for Children-Revised (WISC-R) scores are
significantly lower among the ADHD groups than among normal controls (Barkley,
DuPaul & McMurray, 1990). Research also suggests that children with ADHD are more
likely to be slower in their intellectual development, manifesting scores that average 7 to

15 points below those of control groups on standardized intelligence tests (Faraone et al.,
1993).
ADHD and Cognitive Processes

Some researchers currently characterize ADHD as a condition involving
executive control difficulties that adversely impact cognitive processes such as working
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memory and processing speed (DeFockert, Rees, Frith & Lavie, 2001; Weiler, Bernstein,
Bellinger & Waber, 2000 and 2002).
Both working memory and processing speed are cognitive processes that are
involved to some degree in performance of standardized intelligence tests. Research that
has examined nonverbal working memory impairments has also demonstrated spatial
working memory problems (Cornoldi et aI., 2001). For example, the Arithmetic subtest
of the Wechsler scales involves verbal working memory, and the Coding subtest of the
Wechsler scales is a measure of processing speed, which involves nonverbal working
memory. Processing speed also factors into performance on Wechsler subtests such as
the Block Design, Object Assembly and Picture Arrangement (Wechsler, 1991).
Karatekin and Asarnow (1998) used the Digit Span subtest of the WISC-III to
investigate verbal working memory in participants with childhood onset schizophrenia,
attention deficit hyperactivity disorder, and age-matched controls. Results showed that
normal children recalled more digits than schizophrenic children and ADHD children,
who did not differ in level of performance. Tiholov, Zawallich and Janzen (1996) found
that processing speed, as measured by the WISC-III Processing Speed Index (PSI) was a
significant diagnostic factor differentiating between clinical groups composed of ADHD
and other diagnoses.
The recent revision of the Wechsler scales for children, the Wechsler Intelligence
Scale Fourth Edition (WISC-IV) has placed greater emphasis on working memory and
processing speed as measures of general intellectual functioning. This could have far
reaching implications for the intelligence assessment of ADHD children's cognitive
capabilities. It is very possible that intelligence quotients (IQ's) of ADHD children could

3
be even more negatively impacted. For example, the name change from Perceptual
Organization Index (POI) in WISC-III to Perceptual Reasoning Index (PRI) in WISC-IV
reflects the increased emphasis on fluid reasoning abilities in this index (Wechsler, 2003).
Speed of processing continues to contribute to time bonuses in the Block Design (BD)
subtest. Although BD may be scored with and without time bonuses, only the score with
time bonuses is used in the calculation of PRI and Full Scale Intelligence Quotient
(FSIQ). The comparison of Block Design with time bonuses versus BDN (no time
bonus) gives information about the effect of speed on pelformance. Working memory is
a factor for successful pelformance on PRI subtests such as Picture Concepts. Picture
Concepts appears to measure abstract, categorical reasoning based on perceptual
recognition processes (Sattler& Dumont, 2004). The child must initially recognize or
identify each picture and then determine a quality that a picture in one row shares with a
picture in another row. Therefore, the child needs to rely on stored information while
using fluid reasoning. The Matrix Reasoning subtest involves perceptual reasoning
ability without a speed component. Despite good reasoning and organizational ability,
impulsive responding and poor attention to detail, as well as spatial working memory
problems may result in low scores on this and other PRI subtests.
ADHD, Cognitive Processes and Medication Use

In the US, medication is the most commonly reported form of intervention fOl:
children with ADHD; about 80 percent of the 11 million prescriptions written for
methylphenidate each year are written for children (Purdie, Hattie, & Carroll, 2002).
Given that many ADHD children receive psychopharmacological treatment, the fact that
treated samples show neuropsychological deficits is relevant to many clinicians and
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educators. Consumers of psychological services would also be interested in knowing if
psychostimulants enhance cognitive performance on intelligence tests.
Doyle, et a1. (2000) noted that further study of ADHD persons before and after the use of
stimulant and other medications is necessary to determine the impact of medications on
test sensitivity. Few studies have used full-scale tests of intelligence to measure
medication effects.
A controversial issue related to the treatment of Attention Deficit Hyperactivity
Disorder involves the use of psychostimulant medication in the pediatric population.
Safer, Zito, & Fine (1996) estimated that l.5 million children annually, or 2.8% of the
school-aged population may be using stimulants for behavior management. Barkley
(2006) posited the idea that the impact of drugs upon behavior and concentration was
most salient, with performance on intelligence tests less affected by medication. Research
has consistently shown that psychostimulants have positive effects on hyperactivity,
attention, concentration, and classroom behavior. Short-term positive drug effects are
shown on measures of neurocognitive abilities such as vigilance, fine-motor coordination,
and reaction time. However, research using more traditional measures of cognitive
functioning (e.g. intelligence and achievement tests), and focusing on long-term
improvement are equivocal (Livingston, Mears, Marshall, Gray & Haak, 1996; Mahone,
et aI., 2003). Livingston, et al. (1996) found that that medicated and nonmedicated
children and adolescents with ADHD displayed a similar pattern of intellectual
peIiormance; however, Mahone, et al. (2003) found that the ADHD group performed
more poorly on the WISC-Ill than on the WISC-R. Results of a long term, placebocontrolled study of the stimulant amphetamine in the treatment of ADHD indicates that
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there are remaining positive effects of the drug 15 months after starting treatment
(Gillberg, et aI., 1997). Their results indicated that an amphetamine was clearly superior
to a placebo in reducing inattention, hyperactivity, and other disruptive behaviors; it also
tended to lead to improved results on the WISC-R. Although academic peIformance and
intelligence were not measured in this study, the Multimodal Treatment Study of
Children with ADHD that assessed specific treatment modalities in 579 children, aged 79.9 years with ADHD, Combined Type, clearly demonstrated the benefits of
pharmacotherapy in ADHD children for a sustained period (The MTA Cooperative
Group, 1999).
Previous research has shown that as processing speed, and/or working memory
demands are increased on the Wechsler scales, the IQ's of ADHD students decrease
(Zimmerman & Woo-Sam, 1997). Mahone et aI. (2003) noted, in a comparison of the
WISC-III with the WISC-R, that increased demand for rapid performance in scoring
procedures of the WISC-III may have inadvertently placed a higher demand on executive
control functions of ADHD children, placing this group at a particular disadvantage. The
WISC-IV's demands for further increase in processing speed and working memory have
implications for the cognitive performance of ADHD children. Little empirical
information is available contrasting performance of ADHD children, treated or untreated,
with a normative sample on full-scale tests of intelligence.
As part of the initial validation of the revised edition, the WISC-IV was
administered to 89 children aged 8-13 who were identified as having ADHD according to
DSM-IV -TR diagnostic criteria. Approximately 64% of the children in the ADHD group
were taking medication for ADHD symptomology at the time of testing. Results were
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not reported separately by medication status (medicated/nonmedicated). Compared to a
matched control sample, the group means difference for the PSI reflected a moderate
effect size. Small effect sizes were reported between the Verbal Comprehension Index
(VCI), Working Memory Index (WMI), and Full Scale Intelligence Score (FSIQ). At the
subtest level, the largest effect sizes for group mean scaled score differences were
reported for the Coding and Arithmetic subtests. The other sub tests that measured
working memory and processing speed had modest or small effect sizes. These findings
are somewhat inconsistent with the research literature that suggests significant impact of
ADHD symptomatology on children's ability to perform working memory and
processing speed tasks. One reason for this inconsistency may be the lack of separation
of the ADHD sample into two groups, medicated and nonmedicated. It is possible that
medicated ADHD children had significantly higher scores on all processing speed and
working memory tests relative to nonmedicated ADHD children.
Because the literature lacks clarity in comparing the effect of medication on
ADHD children's' IQ scores, further research is needed. Another question that needs to
be answered is whether or not medication improves IQ scores. The present study was
instigated by the interest in investigating the issues of ADHD and the effects of
medication on cognitive processes in the context of the latest revision of the Wechsler
scales. The WISC-IV is a valid and reliable. instrument with sufficient test sensitivity to
measure the processing demands of working memory and processing speed, as well as the
effects of medication on intelligence test scores.
Because of the change in content and structure of the WISC-IV, and a greater
reliance on working memory and processing speed for successful pelformance, it is very
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possible that the IQ's of ADHD children could be negatively impacted. Additional
research is needed comparing the peIformance of medicated and nonmedicated ADHD
children on the WISC-IV.

Purpose of the Study
The major purpose of this study is twofold: . (1) to determine if ADHD affects the
cognitive processes of working memory and processing speed, and general intellectual
functioning estimates when these cognitive processes are included as measures of ability;
and, (2) to determine what effect, if any, the use of medication in children with ADHD
has on the cognitive processes of working memory, processing speed, and estimates of
general intellectual functioning.

Theoretical Background/Related Research
Definition of ADHD
The chief features of an Attention Deficit Hyperactivity Disorder (ADHD) are
inattention, hyperactivity, and impulsiveness. Current guidelines from the American
Academy of Child and Adolescent Psychiatry and the American Academy of Pediatrics
recommend that a diagnosis of ADHD in children be established based on the criteria
defined by the American Psychiatric Association in the Diagnostic and Statistical Manual
of Mental Disorders, 4th edition (APA, 2000(DSM-IV). DSM-IV is a clinical definition
that specifies symptoms to be met. These include 6 of 9 symptoms either of inattention
or of hyperactivity/impulsivity that had been present before age 7, persists for at least 6
months, is more frequent and severe than is typical for children at comparable ages,
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manifest in multiple settings, and adversely affects functioning (APA, 2000). The DSMJV-TR (2000) now recognizes three subtypes of ADHD. The three categories of ADHD
are Predominately Inattentive Type (ADHDIIT), Predominately Hyperactive-Impulsive
Type (ADHD/HIT), and Combined Type (ADHD/CT).
Power and DuPaul (1996) acknowledged that the DSM-JV definition of ADHD
reflects important changes in our knowledge of ADHD, but fails to account for important
changes in attention and hyperactivity-impulsivity that occur during the course of
development, such as the reduction of hyperactive symptoms.
Wu, Anderson and Castiello (2002) used measures that allowed the isolation of
effect associated with lower level abilities (e.g. speed of processing) when a specific
higher-level cognitive component was examined. They compared their findings with the
predictions of two major models for ADHD, the resource allocation model (which posits
that ADHD is associated with problems in utilizing attentional capabilities in an optimal
manner, but is not associated with attentional incapabilities), and the executive functions
model (interrelated functions responsible for goal-directed behavior). Results suggested
that ADHD may be associated with deficits in speed of processing for verbal response
and sustained attention. Wu, et a1. note that the inhibition and executive dysfunction
models, which describe fast and impulsive responses for ADHD children, have great
difficulty explaining slow speed of processing tapped in their study. They suggest that
ADHD is associated with a state regulation deficit, rather than real limitations of
attentional or executive capabilities.
Recent advancements in medical technology have led to refined causal
explanatory hypotheses of ADHD, implicating dysfunction in the prefrontal-striatal

9

network and brain volume abnormalities that sub serve executive functions and selfcontrol (Barkley, 1998; Castellanos, et a1., 2002). These findings have been incorporated
into recent theories of ADHD, including the working memory model of Rapport and
colleagues (Rapport et aI., 2000; Rapport et aI., 2001), and the disinhibition model of
Barkley (Barkley (1997a, 1997b). ADHD is currently characterized as a condition
involving executive control difficulties that adversely impacts cognitive processes such as
working memory and processing speed. Barkley (2006) noted the utility of the
descriptive approach to diagnose ADHD as delineated in the DSM-N, but found it
unable to account for the many cognitive and behavioral deficits that have emerged in
earlier studies of ADHD (Barkley, DuPaul & McMurray, 1990; Barkley, Grodzinsky &
DuPaul, 1992), and more recently (Barkley, Murphy & Busch, 2001; Mahone, et aI.,
2002; Rucklidge & Tannock, 2001; Warner-Rogers, Taylor, Taylor & Sandberg, 2000).
Prevalence ofADHD

ADHD is the most common neurobehavioral disorder in children, estimated to
affect between 4% and 12% of all school-aged children (APA, 2000). Rowland, Lesesne
& Abramowitz (2002) judged that prevalence estimates of ADHD in school-aged

children ranged between 2% to 18% in community samples. Prevalence estimates vary by
method of ascertainment, diagnostic system, measures used, informants, and the
population cited. There has been a rapid rise in prevalence rates of ADHD (Purdie, Hattie
& Carroll, 2002). A study by Robison, Sclar, Skaer and Galin (1999) found that this

increase in diagnosis was matched with a 2.9-fold increase in the number of ADHD
individuals prescribed stimulant medication. A 2003 United States National Survey of
Children's Health (NSCH) reported that approximately 4.4 million children (7.8%) aged
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5-17 years have been diagnosed with ADHD; of these, 2.5 million (56%) were reported
to be taking medication for the disorder. An estimated 4.3% of children aged 4-17 years
were reported to have had an ADHD diagnosis, and were taking medication for the
disorder. Prevalence of reported ADHD increased with age, and was significantly lower
among children aged 4-8 years, compared with children greater than 9 years (NSCH,
2003). In the 2003 US study, rates of medication treatment varied by age and sex,
ranging from 0.3% to 9.3%. Regardless of sex, overall medication by age patterns were
curvilinear, with prevalence of medication highest among children aged 9-13 years,
compared with younger or older children.
Gender and ethnic disparities exist in study findings concerning diagnosis and
treatment of ADHD. Differences between boys and girls identified as ADHD is
generally under researched. Gaub and Carlson (1997) reviewed 18 studies examining
gender differences in ADHD and found that the ratio of male to female prevalence of
ADHD is 3: 1 in community samples, and between 6: 1 and 9: 1 in clinic-referred samples.
Rates of treatment for ADHD followed the same pattern noted for diagnosis; this means
that males of all ages were more likely to have a history of diagnosis and to take
medication for the disorder. Males aged 16 years had the greatest prevalence of ADHD
diagnosis followed by females aged 11 years (NSCH, 2003).
Studies of females found that ADHD girls, relative to ADHD boys, showed lower
levels of hyperactivity, fewer conduct disorder diagnoses, and lower rates of other
externalizing behavior, but showed greater intellectual impairment (Biederman, et a!.,
1999; Gaub & Carlson, 1997). More recently, Hartung, et a!. (2002) found that boys and
girls ages 3 to 7 years diagnosed with ADHD did not differ on many factors, including
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internalizing symptoms, academic achievement, subtype prevalence, and cognitive
abilities. Their results suggest that the differential referral rates of boys, which is greater
than girls at this age, is likely due to the higher prevalence of disruptive behavior in boys.
NSCH (2003) found prevalence of ADHD diagnosis in the United States to be
significantly higher among non-Hispanic, primarily English speaking, and insured
children. Prevalence rates were significantly higher in families in which the most highly
educated adult was a high school graduate (or had completed 12 years of education),
compared with children in families in which the most highly educated adult had a higher
or lower level of education (NSCH, 2003). Kendall and Hatton (2002) noted that
prevalence rates of ADHD among nonwhite, American ethnic minority groups have not
been established, and the prevalence rates that do exist rarely report the racial
representation of their sample. Findings of several international cross-cultural studies
(Anderson, Williams, McGee & Silva, 1987; Brewis, Schmidt & Meyer, 2001) indicated
that ADHD exists worldwide, with international prevalence rates similar to US rates.
Kendall and Hatton noted that little research has been conducted to describe ADHD in
ethnic and racial groups. Instead, ADHD as a diagnosis has been characterized as a
primarily white, middle class disease, because the majority of the research generated on
this disorder has been based almost exclusively on this population. Kendall and Hatton
suggest that this is due to underlying racist assumptions. They posit the theory that
studies eliminating race as a research variable, in favor of ethnicity as a variable, divert
attention from the root cause of health disparity, which they believe is inequality and
discrimination. In order to eliminate health disparities, Kendall and Hatton see the need
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for researchers to adopt a viewpoint of multiculturalism that acknowledges the cultural
context of all health processes.

Cognitive Processes

Cllld

ADHD

Some contemporary research has focused on the lower cortical cognitive deficits
of working memory and processing speed as it is affected by ADHD (DeFockert, Rees,
Frith & Lavie, 2001; Weiler, Bernstein, Bellinger & Waber, 2000 and 2002). In contrast
to the clinical view that ADHD is primarily an attention deficit (APA, 2000), and is
descriptive in nature, some researchers think that ADHD is a condition involving
executive function deficits that results in specific cognitive difficulties. Barkley (1998)
theorized that ADHD comprises a deficit in behavioral inhibition that is linked to
executive neuropsychological abilities such as working memory and processing speed.
Working memory is defined as the ability to retain, associate, and manipulate online memory storage over a brief time period. Working memory is the ability to actively
maintain information in conscious awareness, pelform some operation or manipulation
with it, and produce a result (Wechsler, 2003). Studies such as Fry and Hale (1996), and
Perlow, Jettuso and Moore (1997), have shown that working memory is an essential
component of fluid reasoning and other higher order cognitive processes, and is closely
related to achievement and learning. The more recent interpretation of working memory
describes it as crucial in the ability to focus. DeFockert, et al. (2001) reported that the
greater the working memory load, the more will an individual be distracted by irrelevant
information. They proposed either that impairment in working memory give rise to
distractibility, or that the opposite occurs. Rapport et al. (2000, 2001) argued that
working memory is the core deficit in ADHD. The impulsivity, distractibility and
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disinhibition associated with ADHD is said to be the result of deficiencies in working
memory.
Many studies show that ADHD children have deficits in working memory, and in
short-term memory relative to children without the disorder (Kempton et a!., 1999;
McInerney & Kerns, 2003; Moore, 2002; Muir-Broaddus, Rosenstein, Medina &
Soderberg, 2002; Rapport et a!. 2000, 2001; Quinlan & Brown, 2003; West, Houghton,
Douglas & Whiting, 2002). Karatekin and Asarnow (1998) investigated verbal and
spatial working memory in participants with childhood onset schizophrenia, attentiondeficit/hyperactivity disorder, and age-matched controls. Using the Digit Span subtest of
the Wechlser Intelligence Scale for Children-3 rd Edition (WISC-III) for verbal working
memory, results showed that normal children recalled more digits than schizophrenic
children and ADHD children, who did not differ. Both schizophrenic and ADHD
children showed deficits in verbal and spatial working memory. A prospective study
examined whether or not neurocognitive pelformance of five and six year old children
later diagnosed with ADHD could contribute to early identification of ADHD. This
study found that children who were rated as ADHD were, 18 months later, significantly
impaired on measures of visuomotor ability and working memory, compared to children
without ADHD (Kalff, et aI., 2002).
Martinussen, Hayden, Hogg-Johnson and Tannock (2005) located and analyzed
26 studies published from 1997 through 2003 that examined at least one of four domains
of working memory (WM) in children 4-18 years old with an IQ greater than 70, and
with ADHD according to DSM (fourth edition or third edition criteria). Non-English
language publications were excluded from the review. A separate meta-analysis was
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pelformed on each WM domain: verbal and spatial storage, and verbal and spatial central
executive function. The studies varied in their controls for potential confounds, such as
co-morbid language, learning, anxiety, or oppositional-defiant disorders. The majority of
the studies had subjects discontinue medication at least 24 hours before testing, but two
studies did not address medication status. The meta-analyses indicated moderate-to-Iarge
WM impairment associated with ADHD in all domains, spatial more than verbal. A test
for publication bias was positive only for studies of verbal storage, indicating that
negative studies of this domain were less likely to be published. A sensitivity analysis
found that when one study of verbal central executive function, which used a
questionable test was removed, the pooled effect size decreased. The meta-analysis
included a relatively small number of studies, especially in the spatial domains.
Therefore, the authors stated that findings should be interpreted with caution, and
considered exploratory in nature. Nonetheless, it was noted that WM deficits
theoretically mesh with research implicating fronto striatal, and dopamine-system
dysfunction in ADHD. Martinussen, et al. speculated that WM deficits may explain
some of the academic difficulties of children with ADHD. In other words, inattention
alone may not fully explain the learning problems that ADHD children experience, both
in the classroom and at home.
Kail (2000) and Kail and Salthouse (1994) have shown that the speed of
information processing is dynamically related to mental capacity, reasoning by the
conservation of cognitive resources, and the efficient use of working memory for higher
order fluid tasks. Donders (1997) showed that processing speed is sensitive to such
neurological conditions as epilepsy, ADHD, and traumatic brain injury. Kail and
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Salthouse (l994) noted that it might be especially important to assess processing speed in
children, because of its relationship to neurological development. They noted that
clinical research in developmental cognitive neuropsychology suggests a dynamic
relationship between working memory, processing speed, and reasoning. For example,
more rapid processing of information may reduce demands on working memory, and
facilitate reasoning. This has implications for performance on tests of intelligence.
Tiholov, Zawallich and Janzen (1996) found that processing speed, as measured
by the WISC-III Processing Speed Index (PSI), was a significant diagnostic factor
differentiating between clinical groups composed of ADHD, and other diagnoses.
Prifitera and Dersh (1993) found that their heterogeneous ADHD samples obtained
scores on the Freedom from Distractibility (FFD) and Processing Speed (PS) factors that
were within 2 points of each other, suggesting possible impairments in the abilities
measured by both of these factors. Relative to their Perceptual Organization Index (POI)
scores, scores on the FFD and PS Indices were approximately 2/3 standard deviation
lower.
In examining the neuropsychological profiles of children with ADHD-IT, and
children with reading disability, Weiler, Bernstein, Bellinger & Waber (2000) found that
children in the former group were more likely to demonstrate poor pelformance on the
Coding and Symbol Search task, whereas those with reading disability were
distinguishable by their poor pelformance on written language measures. Weiler,
Bernstein, Bellinger & Waber (2002) found that children with ADHD were not globally
poor at information processing, neither were they inattentive, but they demonstrated
diminished speed of visual processing. Borger & van der Meere (2000) found that
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looking away behavior was not .associated with the slower reaction times of ADHD
children. Looking away behavior had a negative effect on the accuracy of test
performance of ADHD children only when stimuli were unpredictable. Borger and van
der Meere concluded that the often-reported slowness of ADHD children is not to be
explained by their visual behavior. Ruckledge & Tannock (2002) found that an ADHD
diagnosis, with or without a Reading Disability (RD), was associated with slower
processing speed and naming of objects, poor behavioral inhibition, and greater
variability in reaction times. RD (with or without ADHD) was associated with problems
in verbal working memory, and with slower verbal retrieval speed. ADHD/RD was
additionally associated with slower naming of numbers and colors, and slower overall
reaction times. No gender differences were evident on any measures. Ruckledge and
Tannock concluded that behavior inhibition might not be as central to ADHD deficits as
other neuropsychological indicators.

IQ Tests and Effect of Content

071

ADHD Test Scores

For most intelligence tests in use today, Intelligence Quotient (IQ) Scores are
derived from a composite of tasks that measure different aspects of cognition. The Full
Scale IQ (FSIQ) of the Wechlser Intelligence Scale for Children-3 rd Edition (WISC-ill) is
derived from four index scores, the Verbal Comprehension Index (VCI), Perceptual
Organization Index (POI), Processing Speed Index (PSI), and Freedom from
Distractibility Index (FFD). These index scores are derived from tasks that measure four
different types of cognition: verbal abilities, nonverbal abilities, processing speed, and
working memory, respectively.
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The effects of ADHD on IQ can be greatly influenced by the nature of the
cognitive tasks used to assess intelligence. Several researchers have examined the
predictive or discriminant validity of the WISC-III with respect to ADHD. When studies
examine differences in patterns of cognitive functioning (Mealer, Morgan & Luscomb,
1996; Snow & Snap, 2000), results support the diagnostic utility of WISC-III subtest
profile patterns for ADHD children. Assesmany, McIntosh, Phelps and Rizza (2001)
explored the ability of the WISC-III to discriminate between ADHD and a group of nonADHD children. They also sought to identify which combinations of WISC-III subtests
resulted in the highest level of correct classifications. A stepwise discriminant function
analysis indicated that four WISC-III subtests contributed significantly to the prediction
of group membership: Digit Span, Information, Vocabulary, and Picture Completion.
An overall classification rate of approximately 39% was attained when the four WISC-III
subtests were included in the equation. Approximately 90% of the children classified as
ADHD, and 17.5% of the non-ADHD children were correctly identified when using the
four WISC-III subtests as predictors. Perugini et al. (2000) examined the predictive
power of combined neuropsychological measures for ADHD in children. Among other
measures, the Arithmetic and Digit Span subtests of the WISC-III were administered.
Group differences were significant on the Digit Span, and continuous performance tests
only; however, although these two tests provided the strongest prediction, it was modest
and offered limited diagnostic utility.
In order to evaluate auditory working memory processes in children with ADHD,
numerous researchers have also used the WIC-III tasks subsumed under the FFD index.
Mayes, Calhoun and Crowell (1999) analyzed the WISC-III data in clinical samples of
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ADHD children, and normally developing children. The mean FSIQ exceeded the FFD
at all ages in the ADHD group, but not in the non-ADHD group. Further, the
discrepancy between the FSIQ and FFD was significantly greater in the ADHD group.
The four lowest mean subtest scores for the ADHD group were: Digit Span, Arithmetic,
Coding, and Symbol Search. This differed from the results for the non-ADHD group.
For significantly more children with ADHD (87%), the score for the FFD, plus the PSI,
was less than the sum of the two remaining index scores. Twenty-three percent of the
ADHD children, and none of the non-ADHD group had Digit Span and Arithmetic as
two of their three lowest subtests scores. Krane and Tannock (2001) examined the
WISC-III FFD factor in the diagnosis of ADHD, including the contribution of behavioral,
academic, and language variables to the factor. The WISC-ill FDD subtests, along with
subtests from the WRAT-3, the Woodcock Reading Mastery test-Revised, and the
Clinical Evaluation of Language Fundamentals, were given to 275 children with ADHD.

In contrast to the studies that advocated the diagnostic utility of the FFD index in ADHD,
results from their study showed that a child's FFD score was not a valid diagnostic
indicator either of ADHD, or of a sUbtype of ADHD. FFD scores were associated
primarily with arithmetic and receptive language scores, implicating working memory.
The researchers argue that low FFD scores may signal learning problems, particularly
with arithmetic, language, and working memory that may contribute to poor academic
performance. Similarly, Reinecke, Beebe and Stein (1999) found that despite
significantly lower FFD scores relative to the other WISC-III factor scores of ADHD
children, the vast majority of ADHD children did not show a significantly relative
weakness on this index.
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Research has also indicated that ADHD appears to affect overall level of
performance on Intelligence Tests (IQ Tests). Although IQ's of children with ADHD
appear to be normally distributed (Kaplan, et aI., 2000), research suggests that IQ's are
lower in children with ADHD (Barkley, 1990; Faraone, et aI., 1993; Tripp, Ryan &
Peace, 2002; Zhuang, Liu & Zhang, 2001). According to Barkley (1998), the experiences
that ADHD children have with impairments in behavioral inhibition, and the executive
functions dependent on it, could be expected to result in a small but significant and
negative relationship between ADHD and IQ, particularly verbal IQ. Psychiatric
comorbidity complicates cognitive studies of ADHD; however, studies of comorbid
ADHD children suggest that some intellectual impairment is a core feature of ADHD
syndrome (Barkley, et aI., 1990; Faraone, et aI., 1993).
Recent research suggests that revisions of the Wechsler Scales, with its greater
emphasis on working memory and processing speed (subdomains which are most
affected by ADHD), might adversely impact IQ scores of ADHD children (Barkley,
2000; Mahone, et aI., 2003).
Mahone, et a1. (2003) noted that reviews involving the Wechsler Scales for
children suggest that Full Scale IQ scores on the WISC- III (Wechsler, 1991) average 5 to
6 points lower than scores on the Wechlser Intelligence Scale for Children-Revised
(WISC-R)(Wechsler, 1974), with differences distributed disproportionately over subtests,
i.e., with larger discrepancies found within the Performance Scale. Mahone, et al. (2003)
hypothesized that changes on revised subtests of the WISC-III Pelformance Scale may
place children with ADHD at a disadvantage when compared to their performances on
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analogous WISC-R subtests. They theorized that increased executive demands resulted in.
lower FSIQ scores, and called for further analysis upon future Wechsler revisions.
In their study, Mahone, et al. (2003) examined IQ test peliormance in 122
unmedicated children with ADHD (61 given the WISC-R, 61 given the WISC-III), and
46 children from a healthy comparison group (23 given the WISC-R, 23 given the WISCIII). The ADHD and the comparison group samples were matched for gender and for
Verbal IQ between WISC-R and WISC-III. Children with ADHD had significantly
lower Performance IQ's on WISC-III, compared to their performance on the WISC-R,
with the Picture Arrangement subtest showing the most significant difference. They
found group differences not only among subtests comprising the Freedom from
Distractibility and Processing Speed Indices, but also on subtests comprising the Verbal
Comprehension and Perceptual Organization Indices. Their findings suggested that
children with ADHD may be vulnerable on multiple aspects of the Wechsler Scales, not
only on those known to be associated with working memory or inhibitory control. In
contrast, there were no significant differences between the WISC-R and WISC-III
cohorts on Performance IQ, or any pelformance subtests among the comparison group.
Mahone, et al. (2003) findings are said to lend support to the notion that small
subtest score differences can be expected in unmedicated children with ADHD. They
stated that parameter changes in WISC-III increase demands for executive control, such
as speed and accuracy, as well as a higher demand for precision. Horn-Alsberge (1999)
found that the WISC-III yielded an FSIQ approximately 6 points lower than the WISC-R
among clinical samples composed of children with learning disabilities, ADHD, and
affective disorders. VIQ and PIQ on the WISC-III were also approximately 5 points
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lower than those obtained on the WISC-R. Barkley (2000) also argued that the WISC-III
verbal subtests, particularly those comprising the Freedom from Distractibility (FFD)
Index, might place children with ADHD at a particular disadvantage because they assess
working memory. Mahone, et a1. (2003) cautioned that executive control demands of
subtests of the next revision of the Wechsler Scales should be examined.
These findings related to lower WISC scores of ADHD children are not
surprising, considering the fact that some of the tasks that make up the Wechsler Scales
require the use of working memory and processing speed for effective performance. If
ADHD children were indeed weaker in these cognitive functions, then it would be likely
that their scores on the WISC-R and WISC-III would be somewhat lower than children of
comparable backgrounds without ADHD.
Given the literature that suggests that the cognitive performance of children with
ADHD is adversely affected by the processing demands of working memory and
processing speed, the emphasis of these abilities on intelligence tests would have great
impact on test scores of children diagnosed with ADHD. Schwean, Saklofske, Yackulic
and Quinn (1993) reported on a discriminant validity study of the WISC-III and 45
clinically referred ADHD children, in ,which intercorrelations between subtests, index
scores, and IQ's were examined. Findings revealed that the patterns of correlation for the
ADHD sample were similar to those reported in the WISC-III standardization sample
across parallel age groups. Profitera, Sakolofske and Wiess (2005) contend that these
results indicate that the WISC-III is a highly robust measure that retains it characteristics
when used in an examination of children with ADHD. Given that the WISC-IV
maintains many of the same subtests, and similar factor structure, Profitera et a1. suggest
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that, like its predecessor, the WISC-IV will prove to be a psychometrically sound
instrument applicable for use in assessing ADHD children.
The most recent revision of the Wechsler Intelligence Scales, the Wechlser
Intelligence Scale for Children, Fourth Edition (WISC-IV) has enhanced the measure of
more discrete domains of cognitive functioning (e.g., processing speed, working
memory), yet continue to provide a reliable measure of global intelligence (i.e. FSIQ).
The dual IQ (Verbal and Performance) and index score structure implemented in the
WISC-I1J is no longer utilized. The WISC-IV provides composite or index scores that
represent intellectual functioning in specified cognitive domains, as well as providing a
composite score that represents a child's general intellectual ability (i.e., FSIQ). The four
index scores are: the Verbal Comprehension index (VCl), Perceptual Reasoning Index
(PRI), Working Memory Index (WMI), and the Processing Speed Index (PSI). The VCI
is composed of subtests measuring verbal abilities utilizing reasoning, comprehension,
and conceptualization. The PRI is composed of subtests measuring perceptual reasoning
and organization. The WMI is composed of subtests measuring attention, concentration,
and working memory; and, the PSI is composed of sub tests measuring the speed of
mental and graphomotor processing.
The WISC-IV reflects the current status of intelligence theory that recognizes that
intelligence is composed of an individual's global functioning (behavior as a whole), as
well as specific elements or abilities. The use of Factor Index Scores in the WISC-IV
emphasizes multiple factors in cognitive abilities. The increased emphasis on working
memory recognizes its importance in learning, as well as intelligence. The Working
Memory Index of the WISC-IV comprises the subtests Letter and Number Sequencing, as
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well as Digit Span Forward and Digit Span Backward. Arithmetic, previously a core
subtest, is now a supplemental one. The removal of Arithmetic as a core subtest has
placed more emphasis on active working memory demands. The Processing Speed Index
includes Symbol Search, as well as Coding. The WISC-IV emphasizes the processing
demands for working memory through the renamed WMI (previously called the Freedom
from Distractibility Index or FDD). The WMI includes the subtests, Digit Span and
Letter-Number Sequencing. A new subtest, Cancellation, was developed for the WISCN to provide a supplemental processing speed subtest. The PSI did not increase

processing demands, but Coding and Symbol Search are now core subtests, and
Cancellation is a supplemental subtest. As a result of these changes, it is difficult to know
whether or not WISC-III findings can be generalized to the WISC-N.
The revision to the WISC-N represents a significant shift in composition,
because working memory and processing speed weigh even more heavily now in the
calculation of the Full Scale IQ Score. G. McCloskey (personal communication, April 8,
2004), stated that where working memory and processing speed capacity were critical for
success on two of 10 subtests (or 20% of the content) comprising the FSIQ of the WISC
Ill, these cognitive processes have increased to 4 of the 10 subtests (or 40% of the
content) that comprise the WISC-N Full Scale IQ Score. According to the WISC-N
Technical and Interpretive Manual (Wechsler, 2003), processing speed and working
memory are interrelated. Working memory, with its limited storage capacity, is reliant on
efficient speed of processing information (Wechsler, 2003).
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Because of the changes in content and structure of the WISC-IV and the greater
reliance on working memory and processing speed for successful pelformance, it is very
possible that the IQ's of ADHD children could be negatively impacted ..

Peljormallce of ADHD Sample

all

WIse-IV

As part of the initial validation of the revised edition, the WISC-IV was
administered to 89 children aged 8-13 who were identified as having ADHD according to
DSM-IV -TR diagnostic criteria. The ADHD group was composed of children
representing the various ADHD subtypes (i.e., predominately inattentive, predominantly
hyperactive-impulsive, and combined). Approximately 64% of the children in the
ADHD group were taking medication for ADHD symptomotology at the time of testing.
Table 5.30 and Harcourt Assessment's permission agreement are contained in Appendix
A2 and AI, respectively. It presents the means and standard deviations of the WISC-IV
subtest process task and composite scores for the ADHD group and a matched control
group. The results were as follows: A moderate effect size for the group mean difference
for the PSI was noted, and small effect sizes for the VCI, WMI, and FSIQ were also
observed. At the subtest level, largest effect sizes for group mean scaled score
differences occurred on the Coding and Arithmetic subtests. There were only modest
differences on other subtests that measure working memory and processing speed. Small
effect sizes for group mean scaled score differences occurred on Digit Span, LetterNumber Sequencing, Symbol Search, and Cancellation.
Inspection of this data reveals that relative to the matched control group, children
with ADHD achieved a slightly lower mean performance on the FSIQ (97.6 vs. 102.7).
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These differences in FSIQ are statistically significant (p value

= .01), but the effect size

(.38) is not large. These results are consistent with previous studies indicating that
children with ADHD typically achieve scores near the normative range of intellectual
functioning, but that their performances may be worse on measures of processing speed
and working memory, than on measures of verbal or perceptual-organizational ability
(Barkley, et aI., 2001; Doyle, Biederman, Seidman, Weber & Faraone, 2000). In keeping
with previous findings of the WISC-ill, ADHD children who were administered the
WISC-IV obtained their lowest composite score on the PSI. ADHD children scored
lowest on the Coding subtest. Comparisons with matched controls on the WISC-IV also
suggest that ADHD children score lower than their same-age peers on the WMI. In
keeping with previous findings on the WISC-ill, the score obtained for the Arithmetic
subtest was the lowest of the Working Memory tasks for the ADHD group.
According to the WISC-IV Technical and Interpretive Manual, "additional
research is needed with separate samples of children with ADHD based on subtype, as
well as investigations comparing the performance of medicated and nonmedicated
ADHD children (Wechsler, 2003, p. 89)." Although data exists, and is coded for the
general ADHD sample, the performance of medicated children versus nonmedicated
children has not been analyzed.

ADHD Treatment and Effect on Cognitive Functions
In the United States, medication is the most commonly reported form of
intervention for children with ADHD. Approximately 80 percent of the 11 million
prescriptions written for methylphenidate each year are written for children (Purdie, et
aI.,2002).
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Research suggests that psychostimulant medication may ameliorate ADHD
cognitive deficiencies that adversely impact working memory and processing speed,
although results are equivocal. Studies on the effect of psychostimulants on cognition
and learning vary according to measure and methodology used. Brown and Borden
(1989) suggested that stimulant drug improvement occurs primarily on rote or simple
tasks, and measures emphasizing the processing of higher-order information may be less
influenced. Barkley (1998) noted that the impact of drugs upon behavior and
concentration was most salient, with performance on intelligence tests less affected by
medication. Barkley (1998) also cited research that consistently showed the positive
effects of psychostimulants on hyperactivity, on attention, on concentration, and on
classroom behavior (DuPaul, Barkley, & McMurray, 1994; Pelham & Milich, 1991).
However, most of these studies extrapolated IQ scores either from short forms or from
several subtests of the Wechsler Scales.
Livingston, et al. (1996) failed to detect significant differences on cognitive
functioning between medicated children, nonmedicated children, and adolescents with
ADHD. Their study compared WISC (Revised or Third Edition) scores of medicated
children and nonmedicated children with ADHD. The results of profile analysis
indicated that the profiles were parallel and coincident. Both groups (medicated and
nonmedicated) were characterized by relatively poor performance on the Wechsler
Freedom from Distractibility Index (FDD) factor (i.e., Arithmetic, Digit Span, & Coding
subtests). Livingston, et al. put forth several hypotheses for the discrepancy between the
positive short-term effects of psychostimulants on behavioral and cognitive functioning,
and a lack of parallel long-term improvement on more traditional intellectual,
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neuropsychological and achievement measures. Lack of random assignment to
medicated/nonmedicated groups, and intergroup differences may confound group
comparisons regarding null findings.
Goldstein and Goldstein (1990) noted that psychostimulants enhance the
functioning of subcortical attentional centers; however, they have limited effect on the
informational processing abilities of the cortical areas. Because the measures included in
their studies, and many other similar ones (Kagan, 2000; Saklofske, Schwean &
O'Donnell, 1996; Tannock, Martinussen & Frijters, 2000), primarily assessed cortical
functioning, they would not be expected to detect enhanced subcortical functioning.
Finally, Livingston, et al. (1996) noted the effect of the homeostatic mechanism of downregulation of receptors across brain sites. Neuronal adaptations take place via the
mechanisms of up-regulation or down-regulation. Chronic exposure to stress or to
certain dmgs causes a bombardment by certain excitatory neurotransmitters. This often
leads to down regulation (reduction in the number and density) of excitatory receptors
(Preston, O'Neal & Talaga, 2002). The neural systems responsible for short-term
cognitive gains may down-regulate after prolonged use of psychostimulants, but systems
responsible for behavioral improvements may demonstrate limited down regulation.
Livingston, et al. concluded that failure to document long-term improvement in
neurocognitive abilities should not be taken as an indictment against the use of
psychostimulant medication for attention disorders, simply that ancillary interventions are
needed.
Because many ADHD children receive psychopharmacological treatment, the fact
that treated samples show neuropsychological deficits is relevant to many clinicians and
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educators_ Doyle, et aI. (2000) noted that further study of ADHD persons before, and
after the use of stimulant and other medications, is necessary to determine the impact of
medications on test sensitivity. Fararone (2003) reviewed methods for comparing drugs
across studies, and provided examples of how they can be applied to the medicines that
treat ADHD. He used Cohen's (1988) Standardized Mean Difference (SMD) to report
efficacy in terms of continuous measurements. Faraone calculated effect sizes for
stimulants and nonstimulants in the treatment of ADHD, and found greater effect for
stimulants than nonstimulants (.9 versus .6), with long acting stimulants having a slightly
larger effect size. For example, if a medication increased IQ by 3 points, it would be
considered a small effect, an increase of 7.5 IQ points, a medium effect, and an increase
of 12 IQ points would be considered a large effect size. Faraone found that
nonstimulants increased IQ by 9 points, but stimulants, both immediate release and longacting stimulants, increased IQ by 14 points.
Studies that have examined the short-term effects of methylphenidate on the
WISC-III have failed to reveal significant methylphenidate treatment effects for subtest,
index, or VIQ and PIQ scores (Saklofske, et aI., 1993; Schwean, et aI., 1993). Prifitera,
et aI. (2005) noted that given the results of medication on WISC-Ill performance, it
seems unlikely that the WISC-IV findings that were based on samples of ADHD children
which included a large percentage who were being treated with pharmacological agents,
would have been affected by medication; although, he stated that this was an issue for
future research to address. However, the WISC-IV standardization data was not analyzed
by treatment. It is possible that medicated ADHD children achieved significantly higher
scores on the WISC-IV.
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Despite reported large effect sizes for stimulant medication on intelligence scores
in the Faraone study, the literature on long-term results of psychostimulants on cognitive
functioning is sparse. The results of a long-term, placebo controlled study (Gillberg, et
a1., 1997) of amphetamine in the treatment of ADHD, found that positive effects of the
drug remained 15 months after the start of treatment. With respect to change in WISC-R
scores, a comparison was made between children who had been taking placebo for 6
months or more, with those who had been taking amphetamine for 9 months or more.
Their prediction was that the latter group would show greater increases in IQ scores. The
mean change in IQ from 0 to 15 months was +4.5 (SD, 4.7) in the group treated with
amphetamine for 9 months or more, and +0.7 (SD, 7.2), in the group-receiving placebo
for 6 months or more. In the former group, 28 of 34 individuals changed in a positive
direction as they had predicted, whereas in the latter group, only 4 of 8 did. Verbal
scores did not increase more than performance scores did in any of the groups.
The Multimodal Treatment Study of Children with ADHD (The MTA
Cooperative Group, 1999) assessed specific treatment modalities in 579 children aged 7
to 9.9 years with ADHD, Combined Type. In this 14-month randomized clinical trial,
patients were assigned to various treatment modalities including medical management
(i.e., pharmacotherapy), behavioral treatment, a combination of medical and behavioral
management, or community-based treatment.
Although it did not assess intelligence test scores, the MTA study is presently the
largest study of medication effects on ADHD symptomotology. The results demonstrated
that children receiving medical management, or combined treatment had significantly
greater improvement in hyperactive-impulsive symptoms than those receiving either
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behavioral treatment alone, or community-based treatment. Symptomatic improvement
differences between those receiving only medical treatment, and those receiving
combined treatment were not statistically significant. For other areas of function,
including academic achievement, few differences among the treatments were noted,
except for the reading achievement score on the Wechsler Individual Achievement Test.
The MTA study extended the findings of previous studies that demonstrated short-term,
robust efficacy of medication management, showing that these benefits persist during
treatment up to 14 months. Nevertheless, essentially all recently published practice
guidelines or consensus statements support the use of psychosocial interventions either
alone, or in combination with pharmacotherapy (Dulcan, 1997; NIH consensus statement,
1998; American Academy of Pediatrics Subcommittee on ADHD, 2001). The results of
the MTA study clearly demonstrated the efficacy of medication as a treatment for ADHD
for a sustained period. Less evident is the preferred treatment for the inattentive
symptoms that interfere with cognitive processes.

ADHD Treatment/Gender and Multicultural Differences
As reviewed by Bussing, Zima, Gary and Gat'van (2003), several studies indicate
that girls and children from minority backgrounds are significantly less likely to receive
ADHD treatment, including psychotropic medications, than are boys and Caucasian
children, respectively (Rowland, et al., 2002; Zarin, Suarez & Pincus, 1998). Although
Rowland, et a1. found a similar rate of diagnosis among White and African-American
children, medication treatment rates were higher among White children, particularly
boys, compared with African-American or Hispanic children (8%, 5% and 2%,
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respectively). Bussing, et al., found that boys had more than five times the probability of
receiving an evaluation, an ADHD diagnosis, and treatment than did girls.
A report from the U.S. Department of Health and Human Services (2002) noted
the increase in ADHD diagnosis in children, but lower treatment rates for some groups,
including girls, and minorities receiving care through public service systems. Many
studies showed higher treatment rates for boys than for girls, and for whites as opposed to
nonwhites. This disparity in treatment rates may account for the growing recognition that
many children who do meet the criteria for ADHD are not being treated. The publication
of DSM-N-TR (APA, 2000) text revision, has added new emphasis to the influence of
culture on diagnosis by including an outline for cultural formulation, and a glossary of
culture-bound syndromes. The manual recognizes that culturally diverse individuals
have special needs, and require special skills and knowledge to receive appropriate and
effective treatment.

Conclusions
The DSM-N has contributed to increased accuracy and reliability in the diagnosis
of ADHD, and possibly in its increased prevalence, which is estimated as between 4% to
12% of all school-aged children (APA, 2000). However, the current diagnostic approach
to ADHD is subjective because of its dependency on accuracy of informant report, and
on history. Barkley (1998) theorized that ADHD comprises a deficit in behavioral
inhibition that is linked to neuropsychological abilities. He theorized that ADHD results
in specific cognitive impairments, such as working memory and processing speed
deficits. Wu, et al., (2002) suggested a resource allocation model, in which ADHD is
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associated with a state regulation deficit, rather than real limitations of attention or
executive capacities. Ruckledge and Tannock (2002), from their study differentiating
ADHD from Reading Disabled adolescents, concluded that neuropsychological indicators
such as verbal working memory and processing speed, rather than behavioral inhibition
might be central to ADHD deficits.
Gender and ethnic disparities exist in findings which concern diagnosis and
treatment of ADHD. Yet, the majority of research on ADHD has been based almost
exclusively on white, middle class males. Kendall and Hatton (2002) noted that
prevalence rates of ADHD among nonwhite, American ethnic minority groups are rarely
reported, and have not been established. These researchers posited that this is due to
underlying racist assumptions, calling for the need by researchers to adopt a viewpoint of
multiculturalism that acknowledges the cultural context of all health processes. Findings
of several international cross-cultural studies (Anderson, et al., 1980; Brewis, et al., 2001)
indicate that ADHD exists worldwide, with international prevalence rates similar to US
rates. Treatment of ADHD is also influenced by race and gender, with more
prescriptions written for white, middle class boys. As reviewed by Bussing, et al. (2003),
several studies indicate that girls and children from minority backgrounds are
significantly less likely to receive ADHD treatment than are boys, and Caucasian
children respectively; this treatment includes psychotropic medications (Rowland, et al.,
2002; Zarin, et al., 1998).
Recent advances in medical technology have led to refined causal explanatory
hypotheses of ADHD. ADHD is currently characterized as a condition involving
executive control difficulties. Some contemporary research shows that the cognitive
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processes of working memory and processing speed are most highly affected by ADHD.
Research also indicates that ADHD appears to affect overall level of performance on
intelligence tests (Barkley, 2000; Mahone, et al., 2003).
Research on the performance of ADHD children on standardized intelligence
tests suggests that some degree of intellectual impairment is a core feature of ADHD.
Research also suggests that the effect of ADHD on IQ can be greatly influenced by the
nature of the cognitive tasks used to assess FSIQ. Comparisons of ADHD children and
normative samples on the Wechsler Scales showed differences not only on FSIQ, but also
on index and domain scores. Comparisons of ADHD children on the WISC-R and
WISC-III showed declining scores, suggesting that as processing or executive demands
increase on Wechsler revisions, IQ scores decrease. The latest revision, the WISC-IV,
with its greater contribution of processing speed and working memory to FSIQ, has
implications for cognitive performance of ADHD children.
Psychostimulants are the major intervention for control of ADHD stymptoms.
Studies on the effect of psychostimulants on cognition and learning vary according to the
measure and methodology used. Livingston, et al., (1996) failed to detect significant
differences on cognitive functioning between medicated children, nonmedicated ADHD
children, and adolescents. Both groups were chmacterized by their relatively poor
performance on the WISC-III FDD factor. These authors noted that intergroup
differences and research design might confound group comparisons. They concluded that
failure to document long-term improvement in neurocognitive abilities should not be
taken as an indictment against the use of psychostimulant medication of ADHD, simply
that ancillary interventions are needed.
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Faraone (2003) reviewed methods for comparing medications across studies, and
calculated effect sizes for stimulants and nonstimulants in the treatment of ADHD. Using
Cohen's (1988) standardized mean difference to report efficacy in terms of continuous
measurements, Faraone found greater effect for stimulants, than nonstimulants on
increasing IQ scores. Nonstimulants increased IQ by 9 points, but stimulants, both
immediate release and long acting, increased IQ by 14 points. Despite this finding, the
literature on long-term results of psychostimulants on IQ is sparse. Gillberg, et al. (1997)
found positive effects (increase in IQ) of the drug remained 15 months after the start of
treatment, compared to the placebo group.
The WISC-IV Technical Manual (Wechsler, 2003) compared cognitive
performance of an ADHD sample to a matched control group on WISC-IV subtest,
process task, and composite scores. Results of the comparison found a moderate effect

size for the group mean difference for the PSI, and small effect sizes for the VCI, WMI,
and FSIQ. At the subtest level, the largest effect sizes for group mean scaled score
differences occurred on the Coding and Arithmetic subtests. Only modest differences
were found on other subtests that measured working memory and processing speed. That

is, there were only small effect sizes for the group mean scaled score differences on Digit
Span, Letter-Number Sequencing, Symbol Search, and Cancellation. However, results
were not analyzed separately for treatment effects. It is possible that medicated ADHD
children outperformed nonmedicated samples in comparison to the matched control
group. Additional research is needed to compare cognitive performance of medicated
children with the cognitive pelformance of nonmedicated ADHD children.
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Questions
Given the literature suggesting that executive control difficulties are present in
children with ADHD, and that these difficulties are linked to the cognitive processes of
working memory and processing speed, to what extent do these difficulties impact on the
cognitive performance of ADHD children? What is the effect of ADHD on scores from
intelligence tests such as the WISe-IV, that assess working memory and processing
speed as part of a global estimate of intellectual ability? Is there any difference in the
cognitive performance of medicated children and nonmedicated ADHD children,
compared to the pelformance of a control group of non-ADHD children?
The increased working memory and processing speed task demands of the WISeIV have implications for interpretation of IQ test findings of ADHD children. There is a
paucity of research on the effects of ADHD (with or without medication), on cognitive
abilities as measured by a full-scale intelligence test. The current study will assess the
impact of ADHD on WISe-IV IQ scores, and explore the relationship of medication use
and test scores. The advantage of this study is the comparison of four groups, ADHD
medicated and ADHD nonmedicated children and their matched control groups on the
recent revision of one of the most respected and frequently used, full-scale tests of
intelligence, the WISe-IV. Prifitera, et a1. (2005) indicated that the WISe-IV can
effectively measure the clinical features and cognitive characteristics of ADHD. It also
has considerable clinical value for monitoring cognitive changes of paramount
importance in determining the efficacy of medical, psychological, and educational
programs. An added advantage of the WISe-IV is that it is part of a larger family of
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linked and co-normed tests that are also relevant to diagnosing and assessing children
with ADHD.
The present study will extend the work done by the standardization of the WISelY sample, and explore the differences in cognitive performance between medicated and
nonmedicated ADHD children on the WISe-IV. Results will be compared with the
ADHD standardization sample of the WISe-IV to see if medication significantly
improves pelformance on process/composite scores. Analysis of domain and process
scores will assist in obtaining increased understanding of how ADHD affects the
cognitive processes of working memory and processing speed, and whether or not
medication has a significant effect on WISe-IV scores. These results will help to
elucidate how cognitive deficits associated with ADHD can interfere with measurement
of skills linked to everyday learning activities. Identifying cognitive strengths and
weaknesses may lead to more specific educational planning. Also, consumers may be
better able to make informed decisions about the efficacy of medication as an
intervention for ADHD.

Definition of Terms
Working memory is the ability to attend to and hold information in short-term
memory, while performing some operation or manipulation with it (Wechsler, 2003). For
the purpose of this study, working memory will be measured either by the Working
Memory Index (WMI) standard score of the WISe-IV, or by the subtest scaled scores on
Digit Span and Letter-Number Sequencing. The WMI subtests measure attention,
concentration, and working memory.
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Processing speed is an indication of the rapidity with which one can mentally
process simple or routine information without making errors (Wechsler, 2003). For the
purpose of this study, either the Processing Speed Index (PSI) standard score of the
WISC-IV, or the subtest scaled scores of Coding or Symbol Search will measure
processing speed. The PSI subtests measure the speed of mental and graphomotor
processmg.
Verbal reasoning is the ability to reason with orally presented verbal information.
The Verbal Comprehension subtests of the WISC-IV are designed to measure verbal
reasoning and concept formation (Wechsler, 2003). For the purpose of this study, verbal
comprehension will be measured either as the Verbal Comprehension Index (VCI)
standard score of the WISC-IV, or as the subtest scaled scores of Vocabulary,
Similarities, and Comprehension. The VCI is composed of subtests measuring verbal
abilities utilizing reasoning, comprehension, and conceptualization.
Perceptual Reasoning is the ability to reason with visually presented nonverbal
material. The Perceptual Reasoning Index is designed to measure concept formation with
nonverbal stimuli (Wechsler, 2003). For the purpose of this study, perceptual reasoning
will be measured either by the Perceptual Reasoning Index (PRI) standard score of the
WISC-IV, or by the subtest scaled scores of Block Design, Picture Concepts, and Matrix
Reasoning.
Early intelligence tests emphasized the classification of individuals based on their
overall level of cognitive functioning (Wechsler, 2003). General intellectual functioning
is usually expressed as a summary or composite score, such as the Full Scale IQ (FSIQ).
Sattler (2001) noted that the FSIQ is a global estimate of the child's level of cognitive
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ability; it assesses both crystallized and fluid intelligence. For the purpose of this study,
general intellectual functioning will be defined as the FSIQ composite score of the
WISC-N.
The ADHD sample will be operationally defined as male students between the
ages of 8 and 13 who have been diagnosed with this disorder by a physician or clinical
psychologist and this information has been indicated by a note in their record files.
Medication will be defined as medication used to control for the symptomotology of
ADHD.
Research Hypotheses

Given the literature suggesting that executive control difficulties are present in
children with ADHD, and that these difficulties are linked to working memory and
processing speed which result in lower IQ scores, the following hypotheses will be
studied:
1. It is predicted that ADHD diagnosis has no effect on group mean
FSIQ scores on the WISC-IV. FSIQ scores of an ADHD sample will be
comparable to the FSIQ scores of a matched control nonADHD sample.
2. It is predicted that ADHD diagnosis has no effect on group mean index scores
on the WISC-N as follows:
a. Processing Speed Index (PSI) scores of an ADHD sample will
be comparable to the PSI scores of a nonADHD matched
control sample.
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b. Working Memory Index (WM) scores of an ADHD sample
will be comparable to the WMI scores of a nonADHD matched
control sample.
c. Perceptual Reasoning Index (PRI) scores of an ADHD sample
will be comparable to the PRI scores of a nonADHD matched
control sample.
d. Verbal Comprehension Index (VCI) scores of an ADHD
sample will be comparable to the VCI scores of a nonADHD
matched control sample.
3. It is predicted that ADHD diagnosis has no effect on group mean subtest
scores on the WISC-IV as follows:
a. Coding (CD) subtest scores of an ADHD sample will be
comparable to the CD sub test scores of a nonADHD matched
control sample.
b. Symbol Search (SS) scores of an ADHD sample will be
comparable to the SS subtest scores of a nonADHD matched·
control sample.
c. Letter-Number Sequencing (LN) subtest scores of an ADHD
sample will be comparable to the LN subtest scores of a
nonADHD matched control sample.
d. Digit Span (DS) subtest scores of an ADHD sample will be
comparable to the DS subtest scores of a nonADHD matched
control sample.
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e. Matrix Reasoning (MR) subtest scores of an ADHD sample
will be comparable to the MR subtest scores of a nonADHD
matched control sample.
f.

Picture Concepts (PCn) subtest scores of an ADHD sample
will be comparable to the PCn subtest scores of a nonADHD
matched control sample.

g. Block Design (BD) subtest scores of an ADHD sample will be
comparable to the BD subtest scores of a nonADHD matched
control sample
h. Similarities (SI) subtest scores of an ADHD sample will be
comparable to the SI subtest scores of a nonADHD matched
control sample.
i.

Comprehension (CO) subtest scores of an ADHD sample will
be comparable to the CO subtest scores of a nonADHD
matched control sample.

J.

Vocabulary (VC) subtest scores of an ADHD sample will be
comparable to the results of a nonADHD matched control
sample.

Given the lack of clarity in the literature on the effect of medication on ADHD
children's 1Q scores, the following hypotheses will be studied:
4. It is predicted that ADHD treatment status has no effect on group mean FS1Q
scores. FS1Q scores of an ADHD nonmedicated sample, and an ADHD
medicated sample will be comparable to the FS1Q scores of their nonADHD
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matched controls.
5. It is predicted that ADHD treatment status has no effect on group mean index
scores on the WISC-IV as follows:
a.

Processing Speed Index (PSI) scores of an ADHD
non medicated ADHD sample, and an ADHD medicated
sample will be comparable to the PSI scores of their nonADHD
matched control sample.

b. Working Memory Index (WMI) scores of an ADHD
nonmedicated ADHD sample, and an ADHD medicated
sample will be comparable to the WMI scores of their
nonADHD matched control sample.
c. Perceptual Reasoning Index (PRI) scores of a nonmedicated
ADHD sample, and an ADHD medicated sample will be
comparable to the PRI scores of their nonADHD matched
control sample.
d. Verbal Comprehension Index (VCI) scores of a nonmedicated
ADHD sample, and an ADHD medicated sample will be
comparable to the VCI scores of their nonADHD matched
control sample.
6.

It is predicted that ADHD treatment status has no effect on group mean

subtest scores on the WISC-IV as follows:
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a.

Coding (CD) subtest scores of a nonmedicated ADHD sample, and an
ADHD medicated sample will be comparable to the CD subtest scores
of their nonADHD matched control sample.

b. Symbol Search (SS) subtest scores of a nonmedicated ADHD sample,
and an ADHD medicated sample will be comparable to the SS subtest
scores of their nonADHD matched control sample.
c. Letter-Number Sequencing (LN) subtest scores of a nonmedicated
ADHD sample, and an ADHD medicated sample will be comparable
to the LN subtest scores of their nonADHD matched control sample.
d. Digit Span (DS) subtest scores of a nonmedica(ed ADHD sample, and
an ADHD medicated sample will be comparable to the DS subtest
scores of their nonADHD matched control sample.
e. Matrix Reasoning (MR) subtest scores of a nonmedicated ADHD
sample, and an ADHD medicated sample will be comparable to the
MR subtest scores of their nonADHD matched control sample.

f.

Picture Concepts (PCn) subtest scores of a nonmedicated ADHD
sample, and an ADHD medicated sample will be comparable to the
PCn subtest scores of their nonADHD matched control sample.

g. Block Design (BD) subtest scores of a nonmedicated ADHD sample,
and an ADHD medicated sample will be comparable to the BD subtest
scores of their nonADHD matched control sample.
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h. Similarities (SI) subtest scores of a nonmedicated ADHD sample, and
an ADHD medicated sample will be comparable to the SI subtest
scores of their nonADHD matched control sample.
J.

Comprehension (CO) subtest scores of a nonmedicated ADHD
sample, and an ADHD medicated sample will be comparable to the
CO subtest scores of their nonADHD matched control sample.

j. Vocabulary (VC) subtest scores of a nonmedicated ADHD sample, and
an ADHD medicated sample will be comparable to the VC subtest
scores of their nonADHD matched control sample.
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Chapter 2
Method
Part;c;pants

Data archived in public school files or in the data files of The Psychological
Corporation was accessed to obtain the test score data of 109 male students between the
ages of 8-13, who had been diagnosed with ADHD by a physician or psychologist, and
had been tested on the WISC-IV as part of a school district's educational referral process.
Dates of testing ranged from January 2004 to June 2005 for the nonmedicated ADHD
sample, and January 2003 to July 2005 for the medicated ADHD sample. Archived
public school data was obtained from a northeastern region tri-state area (New Jersey,
Pennsylvania, Delaware, and Maryland). Data on students identified as having other
disabling conditions, such as a specific learning disability were not systematically
excluded from the study.
The ADHD data set was divided into two groups. The first group consisted of test
data from 55 ADHD male students who were not being medicated for ADHD
(nonmedicated). Assignment to this group required: (1) Diagnosis of ADHD, (2) a
WISC-IV Verbal Comprehension Index (VCI) Standard Score greater than 80, (3)
Indication that medication prescribed for the symptoms of ADHD was not being taken at
the time of WISC-IV testing.
The second group consisted of 54 ADHD male students who were medicated for
this disorder. Assignment to this group required: (1) Diagnosis of ADHD, (2) a WISCIV Verbal Comprehension Index (VCI) Standard Score greater than 80, (3) Indication
that medication prescribed for the symptoms of ADHD was being taken prior to, or at the
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time of WISC-N testing. Information on whether or not medication was taken was
based either on parent report, or on information from the student's file.

In addition to the ADHD groups, data was collected for a nonADHD sample. This
nonADHD sample was based on archived data obtained from The Psychological
Corporation of the WISC-N standardization sample of 109 male students between the
ages of 8-15 who were reported as residing in the northeast or north central regions. This
nonADHD sample consisted of two groups. One group, 55 males were matched to the
ADHD nonmedicated group of 55 males. The other group of 54 males was matched to
the examiner's ADHD medicated group of 54 males. The nonADHD control group was
matched on the basis of chronological age, gender, ethnicity, parent education level,
geographic region, and Verbal Comprehension Index.
Ethical considerations assured confidentiality by removing identifying
information such as name and date of birth. Only archived data was collected.
Information collected on data collection forms were secured in a locked file cabinet. Test
scores and protocols collected by the examiner were protected from unauthorized release
and access. Test scores were interpreted in conjunction with other information obtained
about the test taker. The researcher was mindful of practice parameters for the use of
medication in the treatment of children and adolescents. Withholding of treatment was
not prescribed, as the nonmedicated group was predetermined by parental choice. When
analyzing data, consideration was made of such variables as context and culture, as well
as the limitations of current research and practice. The research avoided using
stigmatizing labels. Ecological factors, such as risk and protective factors were
considered when analyzing data.
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Variables
Independent Variables
The primary independent variables in this study were: ADHD diagnostic status
(either ADHD or nonADHD), and treatment status (ADHD medicated or ADHD
nonmedicated) .
Dependent Variables
Dependent variables investigated in the study included WISC-IV FSIQ and PSI,
WMI, PRI, and VCI Index Standard Scores, and all 10 core subtest scaled scores (CD,

SS, LNS, DS, MR, PCn, BD, SI, CO, VC).

Overview of the Research Design
Participants were assigned to groups based on diagnosis and treatment status.
Mean standard scores on the WISC-IV were compared between an ADHD sample, and a
nonADHD matched control sample. Mean standard scores on the WISC-IV were
compared among an ADHD nonmedicated sample, an ADHD medicated sample, and
their nonADHD matched control samples.
Measure and Procedures
A letter requesting permission to collect data was sent to superintendents of
selected schools. Once permission was obtained by return of the signed permission form,
School Psychologists at the selected schools were asked to record WISC-IV test scores
and demographic information from a student's record file on a data collection form. No
identifying information was collected. Data used in this study had already been
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collected. The data collection form requested raw and standard scores of the 10 core
subtests, as well as index scores. The demographic information listed information such as
chronological age, gender, ethnicity, and parent education level. Diagnosis status,
treatment status, brand name of medication, dosage and time medication was taken were
also recorded. Interval data (subtest and composite scores) from the WISC-IV was
collected. Raw and scaled scores were recorded. Obtaining raw scores allowed for a
check of the accuracy of the standard scores.
The use of WISC-IV test scores allowed for comparisons of multiple analyses
(subtest, domain and full scale scores) of ADHD samples, medicated and nonmedicated,
and the nonADHD samples. The WISC-IV is a valid and reliable instrument with
sufficient test sensitivity to measure the processing demands of working memory and
processing speed. More than 60 years of research support the practical and clinical utility
of the Wechsler scales across a wide range of settings and purposes (Sattler, 2001).
These scales have demonstrated clinical utility for purposes as identification of mental
retardation and learning disabilities, placement in specialized programs, clinical
intervention, and neuropsychological evaluation (Beres, Kaufman, & Perlman, 2000).
Further support of a theoretical basis in the Wechsler scales is evident in the appearance
of the same or similar sub tests in other measures of intelligence, and the high correlation
of Wechsler intelligence scales with other measures of cognitive ability (Wechsler,
2003).
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Chapter 3
Results
Results of statistical tests described in Chapter 2 are presented in this chapter. The
aspects of the study that are described include the final composition of the sample, the
statistical analyses used to test the hypotheses, and the results of the data analyses. Data
was initially entered into an excel spreadsheet and then exported to an SPSS file. Data
was analyzed using the Statistical Package for the Social Sciences (SPSS-13.0). The
level of significance criteria for testing hypotheses was set at .05, although the use of the
SPSS data analysis package allows for reporting of specific significance levels for each
hypothesis test.

Demographic Information
The ADHD sample for this study comprised 109 male students between the ages
of 8-13 who had been diagnosed with ADHD, and tested on the WISC-N as part of a
school district educational referral process. The ADHD sample was further divided into
two groups. The first group consisted of 55 ADHD male students who were not being
medicated for their diagnosed ADHD condition. The second group consisted of 54
ADHD male students who were being medicated as part of treatment for the disorder.
The brand name of the ADHD medication were as follows: 19 students were taking
Concerta (35%), 11 students were on Ritalin (5 immediate release, 6 long acting for a
total of 20%), 10 students were taking Adderral (18%), 9 students were on Strattera
(16%), one was on Wellbutrin (2%), one on Medidate (2%), but four of the students'
medication type were not recorded (4% unknown). Thirty-nine of the data forms (71 %)
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indicated that the medications were long acting; five (9%) of the forms indicated
immediate release, and 11 (20%) were not reported. Twenty-five students took their
medications in the morning (45%), one in the afternoon (2%), and two both a.m. and p.m.
(4%). However, medication time was not recorded on twenty-seven data forms (49%).
Two nonADHD samples were then selected from the archived WISC-N
standardization data set obtained form the Psychological Corporation to serve as matched
controls. The nonADHD sample consisted of 109 male students between the ages of 8-15
who were reported as residing in the northeast or north central regions of the tri-state
area. The nonADHD sample was further divided into two control groups. One group of
55 males was matched to the ADHD nonmedicated group (Control 1). A second group of
54 nonADHD males was matched to the ADHD medicated group (Control 2). The
nonADHD control group subjects were matched to the ADHD group subjects on the
basis of chronological age, gender, ethnicity, parent education level, and Verbal
Comprehension Index Standard Score. Appendix B provides a listing of demographic
characteristics of the ADHD samples and their nonADHD matched controls.
Controls were matched to their ADHD counterparts as closely as possible on
chronological age. A majority of the subjects were identical chronological age matches.
Some matches varied by one year, and a few cases varied by two years. The frequency
distributions for age for the four groups, ADHD Nonmedicated, Matched Control 1,
ADHD Medicated, and Matched Control 2 are provided in Table 1.
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Table 1

Frequency Distribution for Age
Age
Group

8

9

10

]1

12

7.00

6.00

8.00

6.00 11.00

13

14

]5

ADHD Nonmedicated
n

17.00

%

30.90

n

14.00 10.00

6.00

2.00

1.00

%

25.50 18.20 14.50 10.90 14.50 10.90

3.60

1.80

12.70 10.90 14.50 10.90 20.00

Control 1a
8.00

6.00

8.00

ADHD Medicated
n
%

7.00

10.00 14.00

13.00 18.50 25.90

5.00

9.00

9.00

9.30 16.70 16.70

Control2 b
n
%

6.00

11.00 13.00

11.10 20.40 24.10

5.00

]0.00

8.00

1.00

9.30 18.50 14.80

1.90

Note. Age range from 8 to 15 years.
aControl 1= nonADHD group matched to ADHD nonmedicated group
bControl 2= nonADHD group matched to ADHD medicated group

The largest proportion of the nonmedicated children were age 8, and the most
frequent age for the medicated children was age 10. These frequencies are consistent
with the literature (NSCH, 2003) that found medication by age patterns were curvilinear,
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with prevalence of medication highest among children aged 9- 13 years, when compared
to younger and older children.
Parent Education level, which ranged from no high school diploma to graduate
and professional school training was matched identically for the majority of the sample.
The frequency distribution for Parent Education Level for the four groups is given in
Table 2.

Table 2
Frequency Distribution for PE
Parent Years of Education

9 - 11

12

13 - 15

16 or more

%

12.70

63.60

10.90

12.70

%

7.30

58.20

16.40

18.20

%

11.10

55.60

9.30

24.10

%

7.40

59.30

13.00

20.40

Diagnostic Group
ADHD Nonmedicated

Control 1

ADHD Medicated

Control 2

Note. 9-11= some high school, 12 years= high school or equivalent, 13-15 years=
some college or associate degree, 16 or more years= college or graduate degree,
Matched control 1= ADHD nonmedicated control, Matched control 2=
ADHD medicated control.
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Parents of both medicated children and non medicated ADHD children most
frequently reported having twelve years of education. Twice as many parents of
medicated ADHD children had 16 or more years of education, when compared to the
parents of nonmedicated children. The parent education distributions reported for the
medicated and nonmedicated ADHD groups are very similar to those reported in the
literature (NSCH, 2003).
The ADHD groups were also matched to controls on the basis of ethnicity. The
frequency distributions for ethnicity for each of the four groups are given in Table 3.

Table 3

Frequency Distribution for Ethnicity
Ethnicity
Group

White

Black

Hispanic

%

78.20

18.20

3.60

%

78.20

18.20

3.60

%

83.30

14.80

l.90

%

85.20

13.00

l.90

ADHD Nonmedicated

Control 1

ADHD Medicated

Control 2

53
FinaUy, the ADHD groups were matched to controls by Verbal Comprehension
Index scores. The characteristics of the ADHD sample and their nonADHD matched
controls are listed in Appendix B. VCl scores of the ADHD groups ranged from a low of
80 to a high of 142. ADHD children with VCl scores below 80 were not included in the
study.
VCl means and standard deviations of the four groups are included in table 4.

Table 4
Verbal Comprehension/ndex Scores by Group

M

SD

ADHD Nonmedicated

101.16

13.07

Control 1

100.93

12.93

ADHD Medicated

101.20

13.69

Control 2

101.31

14.00

Group

Statistical Analysis
Control groups were matched to the ADHD groups on demographic factors of
age, parent education level, ethnicity, and the Verbal Comprehension Index to the degree
that no significant differences were found in the proportions of controls compared to their
ADHD counterparts. Prior to the testing of the study hypotheses, the assumption of
homogeneity of group variances was tested for aU study variables using the Levene
statistic to determine the extent to which the data met the assumptions required for
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appJopriate use of parametric inferential statistical tests of significance. No significant
differences were found among the variable variances of the ADHD groups and their
matched control counterparts, indicating that the use of parametric inferential statistical
procedures was appropriate for all variables used in the study.

Hypotheses Tests

Tests of the hypotheses involving the ADHD and nonADHD samples and their
matched controls utilized three separate analyses:
1) A one-way ANOVA was conducted to test the null hypothesis of no difference
between the mean FSIQ of the nonmedicated and medicated ADHD, and the nonADHD
samples and their matched controls;
2) A MANOVA was conducted to test the hypotheses of no difference between
mean PSI Standard Scores of the ADHD and nonADHD samples, and their matched
controls, no difference between mean WMI Standard Scores of the ADHD and
nonADHD samples, and their matched controls, no difference between mean PRI
Standard Scores. of the ADHD and nonADHD samples and their matched controls, and
no difference between the VCI Standard Scores of the ADHD and nonADHD samples
and their matched controls; and,
3) A MAN OVA was conducted to test the hypotheses of no difference between
mean subtest scaled scores for the ADHD and nonADHD samples and their matched
controls for each of the 10 WISC-IV core subtests (CD, SS, LNS, DS, MR, PCn, BD, SI,
CO, VC).
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Follow-up tests of significant differences were conducted using Fisher's Least
Significant Difference (LSD) statistic.

Results of Hypotheses Tests

The FSIQ, Index, and Subtest means and standard deviations of the four groups
are listed in Tables 5 and 6.

Table 5
Index Mean Score by Group

Diagnostic Group

Index
Scores

ADHD nonMed

Control 1

ADHDMed

Conto12

(N=54)

(N=54)

(N=55)

(N=55)

M

SD

M

SD

M

SD

M

SD

VCI

101.16

13.07

100.93

12.93

101.20

13.69

101.31

14.00

PRI

97.73

13.72

100.20

14.37

103.31

12.47

101.61

14.23

WMI

92.42

1(39

99.11

12.43

95.61

14.13

99.35

12.39

PSI

91.65

11.57

97.16

13.96

94.43

13.99

94.89

14.58

FSIQ

95.64

11.61

99.64

13.79

98.96

12.49

99.57

13.42
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Table 6
Subtest Scores by Group

Diagnostic Group

Subtest
Scores

ADHDNonmed

Control 1

ADHDMed

Contol2

(N=54)

(N=54)

(N=55)

(N=55)

M

SD

M

SD

M

SD

M

SD

SI

10.27

2.72

10.51

2.70

10.61

2.73

10.15

2.98

VC

10.13

2.86

10.31

2.74

10.02

2.73

10.44

2.64

CO

10.33

2.51

9.80

2.48

10.19

2.84

10.20

2.67

BD

9.64

3.26

10.20

2.92

10.17

2.95

10.15

2.81

PCN

10.05

2.83

9.93

2.77

10.91

2.22

10.31

2.49

MR

9.40

2.69

9.89

2.89

10.44

2.79

10.28

3.08

DS

8.64

2.30

10.16

2.63

9.59

2.99

9.98

2.31

DSF

9.00

2.88

10.36

2.50

9.37

2.71

10.15

2.86

DSB

8.83

2.29

9.95

2.62

9.80

3.15

9.93

2.53

LNS

8.89

3.17

. 9.78

2.92

9.11

3.08

9.98

3.16

CD

7.98

2.32

9.40

2.95

8.74

3.17

8.96

2.97

SS

8.93

2.25

9.55

2.82

9.26

2.61

9.20

3.23

Tests of Hypotheses 1 and 4

The omnibus F test applied to the means of the 4 groups (F (3,214) = 1.20, p < .311)
indicated there were no statistically significant differences between the mean FSIQ scores
of any of the groups. The results of the test of Hypotheses 1 and 4 using the univariate
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analysis of variance (ANOVA) for group differences on the dependent variable FSIQ are
given in Table 7.

Table 7

Analysis o/Variance/or FSIQ

SS

d/

MS

F

Sig.

595.255

3

198.418

1.200

0.311

0.017

Tests 0/ Hypotheses 2, 3, 5 and 6
Hypotheses 2, 3, 5, and 6 were analyzed with a multivariate analysis of variance
(MANOVA), to test multiple dependent variables (index or subtest scores)
simultaneously to control for Type 1 error rate inflation that could result from conducting
multiple tests of significance among the dependent variables. Significant differences
found during the multivariate analysis were followed up using Fisher's Least Significant
Difference (LSD) test, with the significance level set a p < .05.
Results of the multivariate analysis tests (MANOVA) of Hypotheses 2 and 5 for
group mean differences on the dependent variables, VCI, PRI, WMI and PSI are given in
Table 8.
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Table 8
Multivariate Analysis for Index Scores

Index
Scores

SS

dj

MS

F

Sig.

VCI

4.361

3

1.454

0.008

0.999

0.000

PRI

913.828

3

304.609

1.617

0.186

0.022

WMI

1769.758

3

589.919

3.703

0.013

0.049

843.775

3

281.258

1.527

0.208

0.021

PSI

17

2

The F test of the group mean differences for WMI was significant (F (3,214)

=

3.70, P < .013). Although statistical differences were found for WMI group mean
differences, the effect size is extremely small (.049). No statistically significant
differences were found among the ADHD, nonADHD, and control groups for VCI, PRI,
or PSI.
The follow-up multiple comparisons of WMI mean scores among the four groups
are shown in Table 9.
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Table 9
WMI Mean Difference Comparisons
Group
Comparison

MD(f

SE

Sig.

ADHD med vs. ADHD nonmed

3.l9

2.418

.188

ADHD nonmed vs. Control 1

-6.99

2.407

.006

ADHD med vs. Control 2

-3.74

2.429

.125

Follow-up tests of significance, conducted to test pair-wise comparisons among
group means on the WMI revealed a statistically significant difference between the
nonmedicated ADHD group and its matched control (p < .006). Pair-wise comparisons
among the groups did not indicate a statistically significant difference on WMI between
the medicated and nonmedicated ADHD groups or between the medicated ADHD group
and its matched control.
Tests of Hypotheses 3 and 6 involved the multivariate analysis of subtest mean
score differences among the various groups. Results of this multivariate are shown in
Table 10.
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Table 10
Multivariate Analysis Results for Subtest Scores

Subtest
Scores

SS

df

MS

F

Sig.

112

SI

7.562

3

2.521

.323

.809

.005

VC

5.367

3

1.789

.237

.871

.003

CO

9.311

3

3.104

.452

.716

.006

BD

12.817

5

4.272

.476

.699

.007

PCn

34.195

3

11.398

1.693

.170

.023

MR

39.340

3

13.113

1.605

.189

.022

DS

76.492

3

25.497

3.842

.010

.051

DSF

64.832

3

21.611

2.858

.038

.039

DSB

45.649

3

15.216

2.149

.095

.030

LNS

44.500

3

14.833

1.554

.202

.021

CD

57.992

3

19.331

2.332

.075

.032

SS

10.561

3

3.520

0.465

.707

.007

The F test of the group mean differences for DS was significant (F (3, 214)

=

3.84, P < .010), but effect size (.051) was extremely small. No statistically significant
differences were found among the ADHD, nonADHD, or control groups for any of the
other subtests.
Tables 11 and 12 show DSF and DSB mean and standard deviation by group.
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Table 11
DSF Subtest Mean and Standard Deviation by Group

Group

M

SD

ADHD Nonmedicated

9.02

2.90

Control 1

10.36

2.50

ADHD Medicated

9.37

2.71

Control 2

10.15

2.86

Table 12
DSB Subtest Mean and Standard Deviation by Group
Group

M

SD

ADHD Nonmedicated

8.83

2.29

Control 1

9.95

2.62

ADHD Medicated

9.80

3.15

Control 2

9.93

2.53

Table 13 shows the follow-up multiple comparisons of DS mean scores among
the four groups.
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Table 13

DS Mean D(fference Comparisons

Group
Comparison

M D(t:

SE

Sig.

ADHD med vs. ADHD nonmed

1.010

0.496

0.044

ADHD nonmed vs. Control 1

-1.530

0.491

0.002

ADHD med vs. Control 2

-0.340

0.498

0.496

Follow-up tests of significance conducted to test pair wise compmisons among
the groups on DS revealed a statistically significant difference between the nonmedicated
ADHD and medicated ADHD group means (p < .044), and a statistically significant
difference between the nonmedicated ADHD group and its matched control group (p <
.002). There was not a statistically significant difference between the DS mean scores of
the medicated ADHD group and its matched control group.
To further examine the difference in Digit Span performance among the groups, a
multivariate analysis was conducted using the separate Digit Span Forward (DSF) and the
Digit Span Backward (DSB) scores. Table 14 shows the results of this additional
analysis.
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Table 14
Multivariate Analysis Resultsfor Digit Span Subtest Subscores

Dependent
Variable

SS

df

MS

F

Sig.

DSF

64.832

3

21.611

2.858

.038

DSB

45.649

3

15.216

2.149

.095

Note. DSF = digit span forward, DSB

= digit span backward

A significant difference was found for DSF (F (3,214)

= 2.858, P < .038), but not

for DSB. Table 15 shows the follow-up multiple comparisons on DSF among the four
groups.

Table 15
DSF Mean Difference Comparisons

Group
Comparison

M Dif.

SE

Sig.

ADHD med vs. ADHD nonmed

0.354

0.539

0.513

ADHD nonmed vs. Control 1

-1.345

0.529

0.012

ADHD med vs. Control 2

-0.776

0.537

0.150

Follow-up tests of significance, conducted to test pair wise comparisons among the
groups on DSF revealed a statistically significant difference between the nonmedicated
ADHD group and its matched control (p <.012). No statistically significant differences
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were found between the medicated and nonmedicated ADHD groups or between the
medicated group and its matched control group.
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Chapter 4
Discussion

Summary of Results
This chapter includes a discussion of the results, with an emphasis toward
understanding and interpreting the data presented and the questions tested. This study
examined the effects of ADHD and medication use on the cognitive processes of
children. Finally, the contributions to the field of psychology, limitations of the study,
and recommendations for future research are discussed.
This study did not find any statistically significant difference between the mean
FSIQs of an ADHD medicated group, and an ADHD nonmedicated group, nor did it find
significant differences between the mean FSIQs of the two ADHD groups, and matched
control samples. This study did find the group mean Working Memory Index score of the
nonmedicated ADHD group to be significantly lower than the group mean Working
Memory Index score of the matched control group. At the subtest level, the group mean
Digit Span subtest score of the nonnmedicated ADHD group was significantly lower than
the Digit Span group means score for the medicated ADHD group, and the matched
control group. At the task level, the Digit Span Forward group mean score for the
nonmedicated ADHD group was lower than the group mean score of the matched control
group. Although ADHD diagnosis appears to have had an effect on WMI performance
for the nonmedicated group, this lower group mean performance did not carryover to
reflect a significant reduction in FSIQ.
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Significance of the Results

Based on the literature, it was anticipated that the ADHD samples would have
significantly lower scores on FSIQ than the non ADHD samples. The revision from the
WISe-III to the WISe-IV represented a significant shift in composition of index and
subtest scores. Now, working memory and processing speed subtests, thought to be the
most vulnerable to the effects of ADHD, weigh even more heavily in the calculation of
the FSIQ of the WISe-IV. The FSIQ findings of the present study were not consistent
with previous research (Barkley, 1990; Barkley, DuPaul & McMurray, 1992; Faraone, et
al., 1993; Tripp, Ryan & Peace, 2002; Zhuang, Liu & Zhang, 2001; Zimmerman & WooSam, 1997), finding lower FSIQ for ADHD samples, because no significant difference
was observed between either of the ADHD groups and their matched controls.
One reason for this study's lack of consistent findings with previous research that
suggests lower FSIQ for ADHD samples may be due to methodological differences.
Unlike this study that matched ADHD with nonADHD on ability level through the Vel,
matching on other studies was frequently done only on the basis of demographic
characteristics. It is very possible that different results would have been obtained if
ability levels were allowed to vary in an uncontrolled manner between the ADHD and
control groups. Under this more rigorous condition of matching subjects by Vel, results
did not find that the addition of PRI, WMI and PSI tasks resulted in decreases in the
FSIQ of ADHD children.
The findings of this study also were not consistent with previous studies which
suggested that the use of medication could have a significant effect on FSIQ scores of
ADHD children (Faraone, 2003; Gillberg, et al., 1997), because no significant differences
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were found between group mean FSIQs of the nonmedicated and medicated groups. The
inconsistency of the present findings with those of previous studies could be due partly to
differences in methodology, such as lack of random assignment to
medicated/nonmedicated groups, as well as intergroup differences that may confound
group comparisons. Faraone (2003) reviewed methods for comparing drugs across
studies and provided examples of how they can be applied to the medicines that treat
ADHD. He used Cohen's (1988) Standardized Mean Differences to report efficacy in
terms of continuous measurements in order to calculate the effect size of medication use.
Limited power, as well as extremely small effect sizes of significant group
differences (shown in Tables 7 and 9) may also contribute to the lack of consistency with
previous findings. There are few studies on the long-term effects of stimulant
medication. Gillberg et a1. used a long-term, placebo-controlled study that found
improved results on the WISC-R with medicated ADHD children. However, the sample
size was small, and type II errors could not be excluded as a possible source of the
differences.
At the Index level, this study found significant differences among the groups only
on the WMI, specifically on DS, in which there was a significant difference between
medicated children and nonmedicated ADHD children, and nonmedicated ADHD
children, and their matched control group. Based on the results of the WISC-IV clinical
study reported in the standardization manual (Wechsler, 2003), in which there was a
moderate effects size for group mean differences on the PSI, similar differences were
expected on the PSI in this study, particularly since the PSI now includes the subtests
Symbol Search, as well as Coding.
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In the standardization study of the WISC-IV (Wechsler, 2003), at the subtest

level, one of the largest effect sizes for group mean scaled score differences occurred on
Coding. Working Memory, as well as Processing Speed, is also dependent on initial
registration of information. The literature (Weiler, Berstein, Bellinger & Waber, 2002;
Ruckledge and Tannock, 2002) suggest that ADHD is associated with problems in verbal
working memory, and slower verbal retrieval speed. Martinussen, Hayden, HoggJohnson and Tannock (2005), in their meta-analysis of working memory in ADHD
children 4-18 years of age, examined separate domains of working memory: verbal and
spatial storage, and verbal and spatial central executive function. Their meta-analyses
indicated moderate-to-Iarge working memory impairment associated with ADHD in all
domains, spatial more than verbal. Limitations included lack of addressing medication
status, small number of studies, especially in the spatial domain, and publication bias.
In light of previous research (Krane & Tannock, 2001; Mayes, Calhoun &
Crowell, 1999) that found significantly lower mean subtest scores for ADHD groups on
Digit Span, Arithmetic, Coding and Symbol Search, greater differences were expected
between the ADHD and non ADHD groups on subtests, as well as index scores. These
expectations existed particularly in light of the greater involvement of attention, working
memory, and executive function processes in completion of the tasks on these subtests.
This study found significant differences among the groups at the subtest level only on
Digit Span. It is conceivable that differences would have been found in performance
among the groups on subtests such as MR and PCn because of the executive functions
involved in the tasks. For example, despite good reasoning and organization ability,
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impulsive responding and poor attention to detail, as well as spatial working memory
problems may result in low scores on these PRI subtests.
Studies that examined the short-term effects of methylphenidate on WISe-III
have failed to reveal significant methylphenidate treatment effects for subtest, index, or
VIQ and PIQ scores (Saklofske, et al" 1993; Schwean, et a1., 1993). Profitera, et a1.,
(2005) noted that given the results of studies indicating the lack of medication effects on
WISe-III performance, it seemed unlikely that the WISe-IV ADHD clinical study that
included a large percentage of children being treated with medication would reflect
significant differences in the performance of ADHD children and matched controls.
However, the standardization sample of the WISe-IV was not separated by medication
effects, so no inferences can be drawn about the differences in performance between
medicated and nonmedicated ADHD children. Although this study grouped medicated
children and nonmedicated ADHD children separately, no attempt was made to control
for medication type, dosage, release times, and duration of medication use. Despite
reported large effect sizes for stimulant medication on intelligence scores in the Faraone
(2003) study, the literature on long-term results of psychostimulants on cognitive
functioning is sparse.
The present study found significantly poorer performance among the ADHD
nonmedicated group than among its matched control on DSF. Hale, Hoeppner and
Fiorello (2002) found Digits Forwards (DF) and Digits Backward (DB) component
scores to be differentially predictive of attention, executive function, and behavior rating
measures. Their results suggest that DB is associated with attention and executive
function processes more than the short term rote auditory memory tapped by DF.
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However, these authors note that DB was only modestly related to attention, executive
function, and teacher rating measures, and not related to parent-reported attention
problems.
The findings of the current study are not inconsistent with Barkley's (1998)
disinhibition model because possible deficits in the executive functions which were
needed to initiate and monitor peIformance on Digit Span may adversely impact
peliormance. ADHD children tend to misperceive the cognitive effort required to
complete tasks, and have difficulty modulating output. Efficient use of executive
functions enables one to use their cognitive processes more efficiently. The poorer
performance on DSF than on DSB in these results may be explained by the position of
DSB in testing (following DSF). Its increased difficulty may serve to cue ADHD
children to engage their mental processes further in the service of better performance.
Although the findings of this study with poorer performance of the ADHD
children on WMI appears consistent with Rapport's (2000, 2001) working memory
model, which posits that working memory is the core deficit in ADHD, Rapport's model
is a very poor fit for the discovery of poorer performance on DSF than on DSB, because
DSB requires much greater involvement of working memory capacities than DSF. The
poorer peIformance on DSF, than on DSB by the ADHD group in this study may be
explained by Wu, Anderson, and Castiello's (2002) resource allocation model of ADHD,
which posits that the poorer performance of ADHD is associated with problems in
utilizing attentional capabilities in an optimal manner, but is not associated with
attentional incapacities.
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Contributions to the Field
This study was the first that attempted to use verbal ability to match controls to
ADHD in order to examine issues such as ADHD vs. nonADHD performance, and
ADHD medicated vs. ADHD nonmedicated performance on factors such as general
estimates of intellectual functioning, working memory, and processing speed. The data
collected offer opportunities for further research to answer additional research questions
about the pelformance of these groups. Although no significant differences were found
in group mean FSIQ differences between ADHD groups and their matched controls, or
between medicated groups and nonmedicated ADHD groups, other aspects of test
performance could be studied. For example, preliminary analyses of the data collected in
this study suggest that it might be fruitful to examine the differences between the ADHD
and control groups in terms of the degree of score differences between Verbal
Comprehension and Working Memory Index scores.
Children with attentional disorders may be more likely to experience problems
with working memory, as suggested by significantly lower scores on the Working
Memory Index. However, it must be a demonstrated fact that this is the case with each
individual child, rather than becoming an assumption that this applies to all children with
this diagnosis, thus being used as a diagnostic marker. Parents of ADHD children should
be made aware of the lack of definitive data on the effects of medication on cognitive
functioning when they are attempting to make decisions about whether or not to use
medication as a treatment for their ADHD children.
In clinical practice, the focus is on individual cases, rather than groups of cases.
The wide variations in the pelformances both of medicated children and of nonmedicated
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ADHD children found in this study, even after matching subjects on the basis of verbal
ability, should serve as caution against overuse of group comparison data to guide
interpretation of cognitive ability profiles. Interpretations regarding the effects of
ADHD, and/or the effects of medication use for ADHD on cognitive functioning need to
be established on a case-by-case basis.

Limitations
This study focused on cross-sectional comparisons of group data, rather than on
longitudinal data for treatment and control groups. For example, it is possible that
medication effects would be found if an ADHD diagnosed group and a non ADHD
control group were tested at time 1, and then retested at time 2 after half of the ADHD
group had begun medication, and the other half had not. Doyle, et a1. (2002) noted that
further study of ADHD persons before and after the use of stimulant, and other
medications is necessary to determine the impact of medication on test sensitivity.
Another limitation of this study is that the method of ADHD diagnosis in this
study could not be ascertained. The gold standard of diagnosis is considered to be the
DSM -IV -TR. Handler (2001) noted there are inherent weaknesses in relying solely on a
clinical classification system for making diagnostic decisions, including issues around the
use of fixed cut-off points, gender differences in the expression of ADHD
symptomatology, duration and pervasiveness criteria, and the employment of potentially
subjective guidelines for diagnosis.
An additional limitation of this study is that data was collected only on children
referred for possible learning disabilities. Co-morbid conditions are a confound when
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analyzing their effects on measures of inte11igence. Co-occurring disorders might have
their own effects on intel1igence, working memory, and processing speed. Additional
research is needed to examine more closely the cognitive abilities of children with
concurrent diagnoses of Learning Disorders and ADHD, in particular; separate samples
of children representing the various subtypes of each disorder is needed. The literature
suggests that ADHDIIT is a distinct syndrome from other sUbtypes; (Barkley, DuPaul &
McMurray, 1992), and unlike the ADHD/HIT that pelform at average lQ levels, the
inattentive subtype negatively impacts cognitive processes. Additional research is
needed to investigate the effect of sUbtype on cognitive processes. Similarly, gender and
racial differences were not studied because of the difficulty in obtaining large samples.
Gaub & Carlson (1997) found greater intel1ectual impairments in girls with this diagnosis
than in boys with the same diagnosis. Future resem:ch investigating the effects of the
moderator variables such as gender and race is needed.

Future Directions for Research
Future research using a chi square analysis of VCIIWMI split differences may
reveal more specific cognitive impairments in ADHD children. These impairments may
not have been shown by the methods and measures used. Examination of the data show
large differences between VCl and WMl scores, suggesting there is a real difference
between ADHD children's verbal reasoning ability and ability to hold information in
short term memory. ADHD children tend to have less working memory capacity relative
to their reasoning ski11s. The difference scores between VCl and WMl could be
calculated and examined statistically for group mean differences, or other statistical tests
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such as chi square analysis could be employed. For example, each group could be split
into two levels: VCl-WMl fewer than 10 points, and VCl-WMl greater than, or equal to
10 points. The proportions could then be tested statistically. This test would answer the
question, "Do more ADHD nonmedicated children have large splits between VCl and
WMl than medicated ADHD children?" "Do more ADHD children have large VCl
minus WMl splits than non ADHD children?" Preliminary analysis of the data suggests
that this is the case. Further analysis would need to be completed to research this topic in
greater depth.
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FEE-WAIVED PERMISSION AGREEMENT
This AGREEMENT entered into as of October 4, 2005, between Harcourt Assessment, Inc.,
19500 Bulverde Road, San Antonio, Texas 78259 (herein the "Publisher") and
Janet Friedman
NAME:
ADDRESS: 9 Gatsby Lane
Berlin, NJ 08009
(herein the "Licensee"), WITNESSETH:
WHEREAS the Publisher is the copyright owner of the 'Vechsler Intelligence Scale for
Children - Fourth Edition Integrated Technical and Interpretive Manual (herein the
"Work(s)"); and
WHEREAS the Licensee wishes to use Table 5.30 from the Work(s) for interpreting and
finalizing Licensee's Doctoral dissertation research results (herein the "Licensed Use").
NOW, THEREFORE, the Publisher and the Licensee agree as follows:
1. The Licensee may either produce, have produced, and/or distribute such reproductions of the

Work specified above, solely for the Licensed Use and subject to the terms and conditions set
forth in this Agreement.

2. The Work(s) shall be identified by title on any reproduction unless otherwise expressly
provided in this Agreement.
3.

The Licensed Use specifically exclude the right to print, copy, or distribute in any form, or
to translate, adapt, or revise, or to exhibit, represent, record, or reproduce any portion of the
Work(s), either separately or as part of any other larger publication, except as otherwise
expressly provided herein. Licensee agrees to abide by copyright, trademark and patent
laws. Licensee agrees to abide by federal copyright, patent, and trademark laws or such other
laws as governed by the Berne Convention, whichever is relevant to Licensee's country.
The Licensee will take all necessary precautions to safeguard all test materials by limiting
access to only those individuals or agencies with a responsible, professional interest in the
test's security.

4. It is understood and agreed that no commercial use, other than as described herein, may be
made 0 f the Work( s) or the reproduction authorized herein.
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5.

All rights in the Work(s) not granted to the Licensee by this Agreement are expressly
reserved to the Publisher.

6

a. The License granted herein shall be for a period commencing with the date first stated
above and terminating October 4, 2006, whereupon the Licensed Use shall cease.
Licensee must obtain written permission for extension of this Agreement
b.
This Agreement may be terminated by either the Publisher or the Licensee upon giving
the other party thirty (30) days prior written notice.

7.

Published reports of the Licensed Use shall not include reproduction of actual test items or
answers unless separate permission is granted in an addendum to this Agreement
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Any reproduction of any portion of the Work(s) or subsequent reference to the Work(s) in
reports/articles resulting from the Licensed Use herein shall bear the following notices:

Wechsler Intelligeltce Scale for Childreft® - Fourth Edition Integrated Teclmical and
Iltterpretive MaftuaL Copyright © 2004 by Harcourt Assessment, Inc. Reproduced with·
permission. All rights reserved.

"Wechsler Intelligence Scale for Children® - Fourth Editiolt Integrated Technical and
Interpretive Manual" and "WISe' are trademarks of Harcourt Assessment, Inc.
registered in the United States of America and/or other jurisdictions.

9. Notices shall appear on the title page (or reverse side of the title page), of each copy of any
reproduction of the Work(s), or, if the Work(s) are reproduced as part ofa larger publication,
at the foot of the first page on which the Work(s) are reproduced. Minor rearrangements of
the above format may be made in publications for purposes of editorial uniformity, but all the
components must be included.
10. If this Agreement covers more than one Work to be reproduced in one publication, the above
model of notice of permission shall be used separately for each separate Work being
reproduced, unless a combined form of notice is specifically approved by rider to this
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11. In any published or unpublished reports of the Licensed Use authorized under this
Agreement, a specific acknowledgement of the permission shall be made, including reference
to the full title of the Work(s), the copyright notice, the author, and the Publisher.
12. The Licensee shall send the Publisher one copy of the Licensed Use reproduced from the
Work(s) under this Agreement.
13. The License granted herein is non-exclusive, and non-transferable to any third party without
permission, in writing, from the Publishef.
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the copyright holder for any third-party material.
16. This Agreement shall only become effective if it is executed by the Licensee within thirty
(30) days of the effective date shown above.
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Appendix A2
Table 5.30 (Wechsler, 2003, p. 88) Mean Performance of ADHD and Matched Control Groups
Subtest!
Process
Score/
Composite

BD
SI
DS
PCn
CD
VC
LN
MR
CO
SS
PCm
CA
IN
AR
WR
BDN
DSF
DSB
CAR
CAS
VCl
PRI
WMI
PSI
FSIQ

AlIention- Deficit
Hyperactiyity Disordet·

Matched Contorl Group

Group Mean Comparison
Standard

Mean

9.9
10.1
9.6
10.5
8.3
9.9
9.3
9.7
9.3

9A
lOA
9.1
9.7
8.7
10.1
9.9
9.6
9.6
8.7
9.5
99
100.1
96.1

93A
97.6

SD

2.9
3.0
3.0
2.8
2.5
2.6
3.5
2.9
2.8
2.7
3.2
2.9
2.8
3.3
2.9
2.8
2.8
3.2
2.9
2.9
13.6
14.2
15.5
12.6
14.0

Mean

lOA
lOA
10.5

lOA
10.0
10.9
10.3
10.3
10.3
10.2
10.7
9.6
11.0
10.8
10.9
10.5
10.5

lOA
9.6

9A
102.5
102.3
101.7
100.7
102.7

SD

N

2.6
2.6
2.9
2.7
2.2
2.8
2.8
2.8
2.5
2.8
3.1
3.0
2.9
2.8
2.7
2.6
2.8
2.8
3.0
2.8
13.2
13.0

89
87
89
89
87
87
89
89
87
89
89
89
88
45
89
89
89
89
89
89
83
89
89
87
82

13A
12.3
12.5

Difference

t yalue

p yalue

Difference"

OA7

1.39
0.82
2.24
-0.25
4.95
2.87
2.03
1.87
2.63
2.17
0.72
1.13
3.35
3.65
2.33
1.80
1.96
1.74
2.15
-0.32
1.81
1.23
2.52
3.88
2.71

0.17

0.17
0.12
0.34
-0.04
0.74

0.33
0.98
-0.10
1.72
1.08
1.00
0.66
1.01
0.89
0.30

OA9
1.30
2.04
0.85
0.58
0.83
0.76
0.90
-0.13

3A3
2.15
5.57
7.30
5.06

OA2
0.03
0.80
<.01
0.01
0.04
0.06
0.01
0.03

OA7
0.26
<.01
<.01
0.02
0.08
0.05
0.09
0.03
0.75
0.07
0.22
0.0]
<.01
0.01

"The Standard Difference is the difference of the two test means divided by the square root of the pooled variance, computed using Cohen's
(J996) Formula lOA.

OAO
0.31
0.24
0.38
0.32
0.10
0.17

OA6
0.67
0.31
0.21
0.29
0.25
0.30
-0.05
0.26
0.16
0.38
0.59
0.38
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Appendix B

ADHD Medicated
ID
CA
Race
1000 10
W
W
1001
10
AA
1003 11
1005 13
W
W
1006 12
1007 10
W
1008
9
W
1009 13
W
W
1010 13
1011
9
W
W
1012 10
AA
1013 12
W
1014 10
AA
1015
8
W
1016
9
W
1017 13
W
1018
8
W
1019 12
W
1020
8
W
1021
9
W
1022
8
W
1023 10
W
1024 10
W
1025 10
1026
8
W
1027 12
W
W
1028 13
1029
8
W
1030
9
W
1032 12
AA
1033
9
AA
W
1034 12
W
1035 11
W
1036
8
W
1037
9
W
1038 12
1039 11
W
1040 11
AA
1041
13
W
W
1042 13
AA
1043 10
W
1044
9
1045 11
W
1046 12
W
1047 12
W
W
1048 10

PED
5
3
3
4
5
3
3
3
3
5
3
2
5
2
3
5
3
3
3
3
3
3
4
3
3
2
2
5
5
3.
2
3
3
4
5
3
3
3
3
3
3
4
5
3
3
3

VCI
142
89
93
95
140
110
91
91
100
119
100
96
106
89
96
128
98
85
87
91
99
99
106
106
87
102
96
126
112
81
95
98
85
110
99
91
112
91
126
95
95
106
100
91
98
93

ADHD Medicated Controls
CA
Race PEDL VCI
9
W
4
142
W
3
87
10
3
93
AA
10
4
96
W
14
5
140
W
12
3
108
W
10
3
91
9
W
3
93
W
13
11
W
3
104
5
119
8
W
3
99
9
W
2
93
13
AA
5
106
10
W
3
87
8
AA
3
96
9
W
13
5
130
W
3
99
8
W
W
3
87
12
3
87
8
W
3
89
9
W
3
99
9
W
3
100
W
10
4
108
10
W
3
106
W
10
3
85
8
W
3
100
11
W
13
W
2
96
5
126
12
W
9
W
5
114
3
81
12
AA
2
93
9
AA
3
98
12
W
3
85
W
12
4
110
8
W
3
99
9
W
3
93
12
W
3
116
11
W
12
AA
3
91
4
124
13
W
3
95
W
13
3
96
10
AA
4
106
9
W
5
100
W
10
3
93
12
W
3
98
12
W
3
93
11
W

2
3

W
W
W
W
W
W
W

5
5
5
3
5

85
95
99
93
100
130
106
112

ADHD Nonmedicated
1053 11
W
W
1054
9
1055 11
W
W
1056 13
W
1057 12
1058 11
W
W
1060 10
11
W
1061
1062 12
W
1063 12
W
1064· 8
W
W
1065
8
W
1066 13
1067 12
W
1068 13
AA
W
1069
9
W
1070
9
W
1071
10
1072 11
W
W
1073 13
1074
8
W
1075
9
W
W
1076
8
1077
9
H
1078 11
W
W
1079
8
W
1080
8
W
1081
9
W
1082
8
AA
1083
9
W
1084 12
W
1085 13
AA
1086 10
AA
1087 10
AA
1088 13
W
1089 13
AA
1090
8
W
1091
8
1092 13
W
W
1093
8
W
1094
8
AA
1095
8

5
5
3
5
3
3
3
2
3
3
4
2
4
3
3
3
4
3
2
5
3
4
2
3
2
5
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2

128
124
112
126
112
100
134
95
91
81
95
95
108
91
95
100
106
83
104
124
96
98
112
85
104
96
100
91
104
91
95
124
85
93
102
112
83
104
98
108
98
81

1049
1050
1051
1052
1110
1111
1112
1113

10
10
10
13

9

9
10
13

H

4

10
11
10
13

9

10
10
13

H

W
W
W
W
W
W
W

2
3
4

5

5
5
3
5

ADHD Nonmedicated
11
W
5
9
W
5
10
W
3
15
W
5
14
W
3
3
13
W
10
5
W
11
3
W

11
12

9

9
13

11
12
9
8

9
11
12
8
9
8
9
12
8
8

9
8

8

12
13
10
10
12
13

8

8
13
8
8
10

W
W
W
W
W
W

AA
W
W

W

W

W

W
W
W
H

W

W
W

W

W
AA

W
W

AA
AA
AA

W

AA
W

W

W
W
AA

3
3

4

2

4
3
3
3
4
3
2
5

3

4

4
3
2
5
3
3
3
3

3

4
3
3
4
3
3
3

3

3
3
3

83
96
104
91
100
132
106
112
Controls
130
124
112
124
112
100
134
95
91
81
93
95
106
93
95
100
106
83
106
121
95
98
110
83
100
95
100
93
104
89
95
124
85
93
104
112
87
104
98
108
96
81

94

1096

1097

1098
1099
1100
1102
1103
1104
1105
1106
1107
1108
1109

11
8
10
13
13
8
8
8
11
10
12
13
8

AA
W

AA
AA
W
W
W
H

W
W
W
W
W

3
3
3
3
3
4
5
3
2
3
3
4
5

93
87
89
110
130
116
102
91
91
91
96
102
102

10
9
11
12
13
8
8
8
10
10
12
14
9

AA
W

AA
AA
W
W
W
H

W
W
W
W
W

3
3
3
5
5
4
5
3
2
3
3
4
5

93
87
91
112
130
114
100
91
89
91
96
102
100

95

